Secondary Logo

Journal Logo


Current World Literature

Current Opinion in Hematology: January 2013 - Volume 20 - Issue 1 - p 66-78
doi: 10.1097/MOH.0b013e32835b82f8
  • Free

This bibliography is compiled by clinicians from the relevant journals scanned by this publication. It is based on the literature regularly pulled into our database from OvidSP (articles are generally added to the database about two and a half months after publication). In addition, the bibliography contains every paper annotated by reviewers; these references were obtained from a variety of bibliographic databases and published between the beginning of the review period and the time of going to press. The bibliography has been grouped into topics that relate to the reviews in this issue.

▪ Papers considered by the reviewers to be of special interest

▪▪ Papers considered by the reviewers to be of outstanding interest

The number in square brackets following a selected paper, e.g. [7], refers to its number in the annotated references of the corresponding review.

Myeloid biology

Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection

Review: (pp. 3–9)

Abdallah DSA, Lin CY, Ball CJ, King MR, et al. Toxoplasma gondii Triggers Release of Human and Mouse Neutrophil Extracellular Traps. Infect Immun 2012; 80:768–777.

▪▪. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532–1535. [02]

▪. Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122:2661–2671. [30]

Chevronnay HPG, Selvais C, Emonard H, Galant C, et al. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. BBA-Proteins Proteomics 2012; 1824:146–156.

Ciledag A, Deniz H, Eledag S, Ozkal C, et al. An aggressive and lethal course of Churg-Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy. Rheumatol Int 2012; 32:451–455.

▪. Döring Y, Drechsler M, Wantha S, et al. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res 2012; 110:1052–1056. [28]

▪▪. Doring Y, Manthey HD, Drechsler M, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012; 125:1673–1683. [27]

Dwivedi N, Upadhyay J, Neeli I, Khan S, et al. Felty's Syndrome Autoantibodies Bind to Deiminated Histones and Neutrophil Extracellular Chromatin Traps. Arthritis Rheum 2012; 64:982–992.

Federzoni EA, Valk PJM, Torbett BE, Haferlach T, et al. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood 2012; 119:4963–4970.

▪. Hakkim A, Fuchs TA, Martinez NE, et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol 2011; 7:75–77. [50]

Honda F, Hane Y, Toma T, Yachie A, et al. Transducible form of p47(phox) and p67(phox) compensate for defective NADPH oxidase activity in neutrophils of patients with chronic granulomatous disease. Biochem Biophys Res Commun 2012; 417:162–168.

Jablonski J, Jablonska E, Leonik A. The Effect of N-nitrosodimethylamine (NDMA) on Bax and Mcl-1 Expression in Human Neutrophils. Bull Environ Contam Toxicol 2011; 87:638–642.

Jeyaseelan S. Comment on ‘‘Innate Immune Collectin Surfactant Protein D Simultaneously Binds Both Neutrophil Extracellular Traps and Carbohydrate Ligands and Promotes Bacterial Trapping’'. J Immunol 2012; 188:3.

Keshari RS, Jyoti A, Kumar S, Dubey M, et al. Neutrophil extracellular traps contain mitochondrial as well as nuclear DNA and exhibit inflammatory potential. Cytom Part A 2012; 81A:238–247.

▪▪. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3:73ra19. [35]

Landoni VI, Chiarella P, Martire-Greco D, Schierloh P, et al. Tolerance to lipopolysaccharide promotes an enhanced neutrophil extracellular traps formation leading to a more efficient bacterial clearance in mice. Clin Exp Immunol 2012; 168:153–163.

▪▪. Leffler J, Martin M, Gullstrand B, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188:3522–3531. [36]

Leffler J, Martin M, Gullstrand B, Tyden H, et al. Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease. J Immunol 2012; 188:3522–3531.

Liu CL, Tangsombatvisit S, Rosenberg JM, Mandelbaum G, et al. Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies - art. no. R25. Arthritis Res Ther 2012; 14:R25.

Lumsden KR, Nelson AM, Dispenza MC, Gilliland KL, et al. Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne. Br J Dermatol 2011; 165:302–310.

Marin-Esteban V, Turbica I, Dufour G, Semiramoth N, et al. Afa/Dr Diffusely Adhering Escherichia coli Strain C1845 Induces Neutrophil Extracellular Traps That Kill Bacteria and Damage Human Enterocyte-Like Cells. Infect Immun 2012; 80:1891–1899.

Menegazzi R, Decleva E, Dri P. Killing by neutrophil extracellular traps: fact or folklore? Blood 2012; 119:1214–1216.

Midgley A, Thorbinson C, Beresford MW. Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology 2012; 51:824–832.

Mori Y, Yamaguchi M, Terao Y, Hamada S, et al. alpha-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps. J Biol Chem 2012; 287:10472–10481.

Narasaraju T, Yang E, Samy RP, Ng HH, et al. Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis. Am J Pathol 2011; 179:199–210.

Nishinaka Y, Arai T, Adachi S, Takaori-Kondo A, et al. Singlet oxygen is essential for neutrophil extracellular trap formation. Biochem Biophys Res Commun 2011; 413:75–79.

Palaniyar N. Response to Comment on ‘‘Innate Immune Collectin Surfactant Protein D Simultaneously Binds Both Neutrophil Extracellular Traps and Carbohydrate Ligands and Promotes Bacterial Trapping’'. J Immunol 2012; 188:3–4.

Palmer LJ, Cooper PR, Ling MR, Wright HJ, et al. Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin Exp Immunol 2012; 167:261–268.

Pawar RD, Pitashny M, Gindea S, Tieng AT, et al. Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice. Arthritis Rheum 2012; 64:1620–1631.

▪▪. Remijsen Q, Vanden Berghe T, Wirawan E, et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 2011; 21:290–304. [40]

Rogers NM, Stephenson MD, Kitching AR, Horowitz JD, et al. Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. Br J Pharmacol 2012; 166: 194–209.

▪▪. Tanikawa C, Espinosa M, Suzuki A, et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun 2012; 3:676. [53]

▪▪. Tillack K, Breiden P, Martin R, et al. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 2012; 188:3150–3159. [55]

Tillack K, Breiden P, Martin R, Sospedra M. T Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses. J Immunol 2012; 188:3150–3159.

Vasu S, Caligiuri MA. Targeted immunotherapy for acute myeloid leukemia. Best Pract Res Clin Haematol 2011; 24:533–540.

▪▪. von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209:819–835. [23]

Yamada M, Kubo H, Kobayashi S, Ishizawa K, et al. The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cell Mol Immunol 2011; 8:305–314.

Yan J, Meng XM, Wancket LM, Lintner K, et al. Glutathione Reductase Facilitates Host Defense by Sustaining Phagocytic Oxidative Burst and Promoting the Development of Neutrophil Extracellular Traps. J Immunol 2012; 188:2316–2327.

Neutrophil apoptosis and its induction as a potential treatment for chronic inflammatory disease

Review: (pp. 10–15)

Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in Cardiovascular Biology and Disease. Arterioscler Thromb Vasc Biol 2012; 32:223–229.

Blomgran R, Desvignes L, Briken V, Ernst JD. Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells. Cell Host Microbe 2012; 11:81–90.

Chaung WW, Wu RQ, Ji YX, Wang ZM, et al. Peripheral Administration of Human Adrenomedullin and Its Binding Protein Attenuates Stroke-Induced Apoptosis and Brain Injury in Rats. Mol Med 2011; 17:1075–1083.

Davies EH, Mengel E, Tylki-Szymanska A, Kleinotiene G, et al. Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool. J Inherit Metab Dis 2011; 34:1053–1059.

Elks PM, van Eeden FJ, Dixon G, Wang XG, et al. Activation of hypoxia-inducible factor-1 alpha (Hif-1 alpha) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 2011; 118:712–722.

Federzoni EA, Valk PJM, Torbett BE, Haferlach T, et al. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood 2012; 119:4963–4970.

Filipovic B, Kovcevic N, Randjelovic T, Kostic S. Nutritional Status in Hospitalized Patients in the Department of Gastroenterohepatology. Hepato-Gastroenterol 2011; 58:1229–1234.

Francis N, Wong SH, Hampson P, Wang KQ, et al. Lactoferrin inhibits neutrophil apoptosis via blockade of proximal apoptotic signaling events. Biochim Biophys Acta-Mol Cell Res 2011; 1813:1822–1826.

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107–120.

Geering B, Simon HU. A novel signaling pathway in TNF alpha-induced neutrophil apoptosis. Cell Cycle 2011; 10:2821–2822.

Geering B, Simon HU. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ 2011; 18:1457–1469.

Horvath KM, Herbst M, Zhou HB, Zhang HT, et al. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus - art. no. 102. Respir Res 2011; 12:4.

Hsing CH, Chen YH, Chen CL, Huang WC, et al. Anesthetic Propofol Causes Glycogen Synthase Kinase-3 beta-regulated Lysosomal/Mitochondrial Apoptosis in Macrophages. Anesthesiology 2012; 116:868–881.

Itoh S, Yokoyama R, Murase C, Takii T, et al. Staphylococcal superantigen-like protein 10 binds to phosphatidylserine and apoptotic cells. Microbiol Immunol 2012; 56:363–371.

Kirschnek S, Vier J, Gautam S, Frankenberg T, et al. Molecular analysis of neutrophil spontaneous apoptosis reveals a strong role for the pro-apoptotic BH3-only protein Noxa. Cell Death Differ 2011; 18:1805–1814.

Koshio O, Nagao T, Mabuchi A, Ono Y, et al. Apoptotic signaling in endothelial cells with neutrophil activation. Mol Cell Biochem 2012; 363:269–280.

Krysko DV, Kaczmarek A, Krysko O, Heyndrickx L, et al. TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation. Cell Death Differ 2011; 18:1316–1325.

Kuiper JWP, Forster C, Sun C, Peel S, et al. Zoledronate and pamidronate depress neutrophil functions and survival in mice. Br J Pharmacol 2012; 165:532–539.

Kuriwada T, Kumano N, Shiromoto K, Haraguchi D. The Effect of Inbreeding on Mating Behaviour of West Indian Sweet Potato Weevil Euscepes postfasciatus. Ethology 2011; 117:822–828.

Laurent J, Faes-van't Hull E, Touvrey C, Kuonen F, et al. Proangiogenic Factor PlGF Programs CD11b(+) Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors. Cancer Res 2011; 71: 3781–3791.

▪▪. Leitch AE, Lucas CD, Marwick JA, et al. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ 2012. [20]

Liu LL, Lin LR, Lu CX, Fu JG, et al. Expression of inflammatory and apoptosis factors following coronary stent implantation in coronary heart disease patients. Int Immunopharmacol 2011; 11:1850–1854.

Lopatniuk P, Witkowski JM. Conventional calpains and programmed cell death. Acta Biochim Pol 2011; 58:287–296.

Maddigan A, Truitt L, Arsenault R, Freywald T, et al. EphB Receptors Trigger Akt Activation and Suppress Fas Receptor-Induced Apoptosis in Malignant T Lymphocytes. J Immunol 2011; 187:5983–5994.

McDermott DH, Liu Q, Ulrick J, Kwatemaa N, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 2011; 118:4957–4962.

▪. McGrath EE, Marriott HM, Lawrie A, et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol 2011; 90:855–865. [31]

Meeths M, Chiang SCC, Wood SM, Entesarian M, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood 2011; 118:5783–5793.

Moret I, Lorenzo MJ, Sarria B, Cases E, et al. Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. Eur Resp J 2011; 38:1158–1164.

Moret I, Lorenzo MJ, Sarria B, Menendez R. Increased lung neutrophil apoptosis and inflammation resolution. Eur Resp J 2012; 39:790–791.

Na H, Acharjee S, Jones G, Vivithanaporn P, et al. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence - art. no. 44. Retrovirology 2011; 8:6.

Paunel-Gorgulu A, Kirichevska T, Logters T, Windolf J, et al. Molecular Mechanisms Underlying Delayed Apoptosis in Neutrophils from Multiple Trauma Patients with and without Sepsis. Mol Med 2012; 18:325–335.

Persson CGA, Uller L. Increased lung neutrophil apoptosis and inflammation resolution. Eur Resp J 2012; 39:789–790.

Rahman R, Chaudhary R, Anand N. Verification of posterior hyaloid status during pars plana vitrectomy, after preoperative evaluation on optical coherence tomography. Retin-J Retin Vitr Dis 2012; 32:706–710.

Richard-Devantoy S, Gorwood P, Annweiler C, Olie JP, et al. Suicidal Behaviours in Affective Disorders: A Deficit of Cognitive Inhibition? Can J Psychiat-Rev Can Psychiat 2012; 57:254–262.

Rydell GE, Kindberg E, Larson G, Svensson L. Susceptibility to winter vomiting disease: a sweet matter. Rev Med Virol 2011; 21:370–382.

Schwartz JT, Barker JH, Kaufman J, Fayram DC, et al. Francisella tularensis Inhibits the Intrinsic and Extrinsic Pathways To Delay Constitutive Apoptosis and Prolong Human Neutrophil Lifespan. J Immunol 2012; 188:3351–3363.

Steller EJA, Rinkes I, Kranenburg O. How CD95 stimulates invasion. Cell Cycle 2011; 10:3857–3862.

Sun Y, Karmakar M, Taylor PR, Rietsch A, et al. ExoS and ExoT ADP Ribosyltransferase Activities Mediate Pseudomonas aeruginosa Keratitis by Promoting Neutrophil Apoptosis and Bacterial Survival. J Immunol 2012; 188:1884–1895.

Tang YZ, Orth JD, Xie T, Mitchison TJ. Rapid induction of apoptosis during Kinesin-5 inhibitor-induced mitotic arrest in HL60 cells. Cancer Lett 2011; 310:15–24.

Thakur ML, Zhang KJ, Paudyal B, Devakumar D, et al. Targeting Apoptosis for Optical Imaging of Infection. Mol Imaging Biol 2012; 14:163–171.

Thoren FB, Riise RE, Ousback J, Della Chiesa M, et al. Human NK Cells Induce Neutrophil Apoptosis via an NKp46-and Fas-Dependent Mechanism. J Immunol 2012; 188: 1668–1674.

▪▪. Thoren FB, Riise RE, Ousback J, et al. Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J Immunol 2012; 188:1668–1674. [23]

Wang JH, Peng Y, Yang LL, Wang YB, et al. Escherichia coli induces apoptosis in human monocytic U937 cells through the Fas/FasL signaling pathway. Mol Cell Biochem 2011; 358:95–104.

▪▪. Wang K, Hampson P, Hazeldine J, et al. Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis. PLoS One 2012; 7:e30128. [19]

Wang XH, Katayama A, Wang YY, Yu L, et al. Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4. Cancer Res 2011; 71:7410–7422.

Wu LK, Al-Hejazi A, Filion L, Ben R, et al. Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study. Cytotherapy 2012; 14:1–10.

Wu Y, Zhao QY, Peng C, Sun L, et al. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 2011; 225:438–447.

Xu G, Ahn J, Chang S, Eguchi M, et al. Lipocalin-2 Induces Cardiomyocyte Apoptosis by Increasing Intracellular Iron Accumulation. J Biol Chem 2012; 287:4808–4817.

Yang EJ, Choi E, Ko J, Kim DH, et al. Differential effect of CCL2 on constitutive neutrophil apoptosis between normal and asthmatic subjects. J Cell Physiol 2012; 227:2567–2577.

Zhang YZ, Lin XC, Koga K, Takahashi K, et al. Strain Differences in Alveolar Neutrophil Infiltration and Macrophage Phenotypes in an Acute Lung Inflammation Model. Mol Med 2011; 17:780–789.

Lessons from rare maladies: leukocyte adhesion deficiency syndromes

Review: (pp. 16–25)

Adler G, Steeg C, Pfeffer K, Murphy TL, et al. B and T Lymphocyte Attenuator Restricts the Protective Immune Response against Experimental Malaria. J Immunol 2011; 187:5310–5319.

Akishima-Fukasawa Y, Ishikawa Y, Akasaka Y, Uzuki M, et al. Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer. Histopathology 2011; 59:470–481.

Al-Dhekri H, Al-Mousa H, Ayas M, Al-Muhsen S, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Leukocyte Adhesion Deficiency Type 1: A Single Center Experience. Biol Blood Marrow Transplant 2011; 17:1245–1249.

Andersson M, Lutay N, Hallgren O, Westergren-Thorsson G, et al. Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses. Innate Immun 2012; 18:531–540.

Bailey AR, Hou HY, Obregon DF, Tian J, et al. Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-alpha: implications for autism. Faseb J 2012; 26:1040–1051.

Buss EC, Ho AD. Leukemia stem cells. Int J Cancer 2011; 129:2328–2336.

Chavakis T. Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof. Eur J Clin Invest 2012; 42:686–691.

▪. Costantini C, Calzetti F, Perbellini O, et al. Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood 2011; 117:1677–1686. [23]

Crosslin DR, McDavid A, Weston N, Nelson SC, et al. Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum Genet 2012; 131:639–652.

Cury-Boaventura MF, Gorjao R, de Lima TM, Fiamoncini J, et al. Effect of medium/omega-6 long chain triglyceride-based emulsion on leucocyte death and inflammatory gene expression. Clin Exp Immunol 2011; 165:383–392.

Forcelini CM, Dantas CM, Luz C, Santin R, et al. Analysis of Leukocytes in Medication-Overuse Headache, Chronic Migraine, and Episodic Migraine. Headache 2011; 51:1228–1238.

Graubert TA, Mardis ER. Genomics of Acute Myeloid Leukemia. Cancer J 2011; 17:487–491.

Hamed YB, Medjdoub A, Kara BM, Merzouk H, et al. 5,6-Dihydro-2H-pyranones and 5,6-dihydro-2H-pyridones and their derivatives modulate in vitro human T lymphocyte function. Mol Cell Biochem 2012; 360:23–33.

▪▪. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci 2012; 1250:50–55. [26]

Harikrishnan R, Kim JS, Kim MC, Balasundaram C, et al. Expressed sequence tags (ESTs) based identification of genes and expression analysis of leukocyte cell-derived chemotaxin-2 (LECT2) from Epinephelus bruneus. Gene 2012; 491:88–101.

Harris ES, Smith TL, Springett GM, Weyrich AS, et al. Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): Molecular characterization of the defect in an index family. Am J Hematol 2012; 87:311–313.

Ho PA, Kutny MA, Alonzo TA, Gerbing RB, et al. Leukemic Mutations in the Methylation-Associated Genes DNMT3A and IDH2 Are Rare Events in Pediatric AML: A Report From the Children's Oncology Group. Pediatr Blood Cancer 2011; 57:204–209.

▪. Hogg N, Patzak I, Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat Rev Immunol 2011; 11:416–426. [24]

▪▪. Hyun YM, Sumagin R, Sarangi PP, et al. Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels. J Exp Med 2012; 209:1349–1362. [19]

Katagiri K, Ueda Y, Tomiyama T, Yasuda K, et al. Deficiency of Rap1-Binding Protein RAPL Causes Lymphoproliferative Disorders through Mislocalization of p27kip1. Immunity 2011; 34:24–38.

Kito Y, Ito T, Tokura Y, Hashizume H. High-dose Intravenous Immunoglobulin Monotherapy for Drug-induced Hypersensitivity Syndrome. Acta Derm-Venereol 2012; 92: 100–101.

Madkaikar M, Currimbhoy Z, Gupta M, Desai M, et al. Clinical profile of leukocyte adhesion deficiency type I. Indian Pediatrics 2012; 49:43–45.

Mesti T, Setina TJ, Vovk M, Novakovic BJ. Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana. Med Oncol 2012; 29:1217–1222.

Meyer LH, Debatin KM. Diversity of Human Leukemia Xenograft Mouse Models: Implications for Disease Biology. Cancer Res 2011; 71:7141–7144.

Naude CE, Bouic P, Senekal M, Kidd M, et al. Lymphocyte measures in treatment-naive 13-15-year old adolescents with alcohol use disorders. Alcohol 2011; 45:507–514.

O'Connell RM, Zhao JL, Rao DS. MicroRNA function in myeloid biology. Blood 2011; 118:2960–2969.

Oya Y, Watanabe N, Kobayashi Y, Owada T, et al. Lack of B and T lymphocyte attenuator exacerbates autoimmune disorders and induces Fas-independent liver injury in MRL-lpr/lpr mice. Int Immunol 2011; 23:335–344.

Park KS, Sedlock DA, Navalta JW, Lee MG, et al. Leukocyte apoptosis and pro-/anti-apoptotic proteins following downhill running. Eur J Appl Physiol 2011; 111:2349–2357.

Paun O, Lazarus HM. Novel Transplant Strategies in Adults with Acute Leukemia. Hematol Oncol Clin North Am 2011; 25:1319.

Persson C, Uller L. Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development. Br J Pharmacol 2012; 165:2100–2109.

▪. Peters T, Bloch W, Pabst O, et al. Adaptive immune response to model antigens is impaired in murine leukocyte-adhesion deficiency-1 revealing elevated activation thresholds in vivo. Clin Dev Immunol 2012; 2012:450738. [61]

Sachs RK, Johnsson K, Hahnfeldt P, Luo J, et al. A Multicellular Basis for the Origination of Blast Crisis in Chronic Myeloid Leukemia. Cancer Res 2011; 71:2838–2847.

Schild L, Lendeckel U, Gardemann A, Wiswedel I, et al. Composition of molecular cardiolipin species correlates with proliferation of lymphocytes. Exp Biol Med 2012; 237: 372–379.

▪▪. Schmidt S, Nakchbandi I, Ruppert R, et al. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J Cell Biol 2011; 192:883–897. [89]

Silverberg JI, Kleiman E, Silverberg NB, Durkin HG, et al. Chickenpox in childhood is associated with decreased atopic disorders, IgE, allergic sensitization, and leukocyte subsets. Pediatr Allergy Immunol 2012; 23:50–58.

▪. Stadtmann A, Brinkhaus L, Mueller H, et al. Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur J Immunol 2011; 41:2074–2085. [13]

Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr 2012; 24:1–8.

Ueharaguehi Y, Kabashima K, Shimizuhira C, Nakajo W, et al. Multiple Follicular Pustules as an Atypical Cutaneous Manifestation of Drug-induced Hypersensitivity Syndrome. Acta Derm-Venereol 2011; 91:728–729.

▪. van de Vijver E, De Cuyper IM, Gerrits AJ, et al. Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin beta1 and beta3 in platelet adhesion to collagen. Blood 2012; 119:583–586. [82]

van de Vijver E, De Cuyper IM, Gerrits AJ, Verhoeven AJ, et al. Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin beta 1 and beta 3 in platelet adhesion to collagen. Blood 2012; 119:583–586.

▪▪. van de Vijver E, Maddalena A, Sanal O, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 2012; 48:53–61. [28]

van de Vijver E, Maddalena A, Sanal O, Holland SM, et al. Hematologically important mutations: Leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 2012; 48:53–61.

▪. Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 2012; 19:212–217. [12]

Wallbrecht K, Drick N, Hund AC, Schon MP. Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Exp Dermatol 2011; 20:980–985.

Watanabe H, Koide R, Iijima M. Toxic Epidermal Necrolysis Arising as a Segue la of Drug-induced Hypersensitivity Syndrome. Acta Derm-Venereol 2012; 92:214–215.

Yamamoto N, Honma M, Suzuki H. Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders. Mol Pharmacol 2011; 80:466–475.

▪▪. Ye F, Petrich BG. Kindlin: helper, co-activator, or booster of talin in integrin activation? Curr Opin Hematol 2011; 18:356–360. [47]

▪. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 2011; 118:6743–6751. [05]

Acute febrile neutrophilic dermatosis (Sweet's syndrome)

Review: (pp. 26–35)

Adamski JM, Peters JA, Danieloski R, Bacarin MA. Excess iron-induced changes in the photosynthetic characteristics of sweet potato. J Plant Physiol 2011; 168:2056–2062.

Agharbi FZ, Meziane M, Harmouche T, Elhatimi A, et al. Sweet's syndrome revealing a lymph node tuberculosis. Ann Dermatol Venereol 2011; 138:605–606.

Albuquerque LC, Inoue-Nagata AK, Pinheiro B, Ribeiro SD, et al. A novel monopartite begomovirus infecting sweet potato in Brazil. Arch Virol 2011; 156:1291–1294.

Apalla Z, Kanatli L, Sotiriou E, Manousari A, et al. Histiocytoid Sweet syndrome. Clin Exp Dermatol 2011; 36:562–563.

Ardes-Guisot N, Alonzi DS, Reinkensmeier G, Butters TD, et al. Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain. Org Biomol Chem 2011; 9:5373–5388.

Bastidas N, Levine JP, Stile FL. The ‘‘Sweet Science’' of Reducing Periorbital Lacerations in Mixed Martial Arts. Ann Plast Surg 2012; 68:43–45.

Battistella M, Bourrat E, Fardet L, Saada V, et al. Sweet-Like Reaction Due to Arthropod Bites: A Histopathologic Pitfall. Am J Dermatopathol 2012; 34:442–445.

Baybay H, Elhatimi A, Idrissi R, Gallouj S, et al. Sweet's syndrome following oral ciprofloxacin therapy. Ann Dermatol Venereol 2011; 138:606–607.

Bechoff A, Poulaert M, Tomlins KI, Westby A, et al. Retention and Bioaccessibility of beta-Carotene in Blended Foods Containing Orange-Fleshed Sweet Potato Flour. J Agric Food Chem 2011; 59:10373–10380.

▪▪. Bidinger JJ, Sky K, Battafarano DF, Henning JS. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome. J Am Acad Dermatol 2011; 65:184–191. [59]

Bollaert M, Jeulin H, Waton J, Gastin I, et al. Six cases of spring DRESS. Ann Dermatol Venereol 2012; 139:15–22.

Byrd-Bredbenner C, Johnson M, Quick VM, Walsh J, et al. Sweet and salty. An assessment of the snacks and beverages sold in vending machines on US post-secondary institution campuses. Appetite 2012; 58:1143–1151.

Cartee TV, Chen SC. Sweet Syndrome Associated With Hydralazine-Induced Lupus Erythematosus. Cutis 2012; 89:121–124.

Chen HJ, Wu SD, Huang GJ, Shen CY, et al. Expression of a cloned sweet potato catalase SPCAT1 alleviates ethephon-mediated leaf senescence and H2O2 elevation. J Plant Physiol 2012; 169:86–97.

Chen HJ, Wu SD, Lin ZW, Huang GJ, et al. Cloning and characterization of a sweet potato calmodulin SPCAM that participates in ethephon-mediated leaf senescence, H2O2 elevation and senescence-associated gene expression. J Plant Physiol 2012; 169:529–541.

Choi JH, Stubblefield B, Cookson MR, Goldin E, et al. Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations. Mol Genet Metab 2011; 104:185–188.

▪. Cohen P, Honigsmann H, Kurzrock R. Acute febrile neutrophilic dermatosis: In: Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K (eds): Fitzpatrick's dermatology in general medicine., 8th ed. New York: McGraw-Hill Professional 2012; 362–371. [02]

Coleman J, Williams A, Phan THT, Mummalaneni S, et al. Strain differences in the neural, behavioral, and molecular correlates of sweet and salty taste in naive, ethanol- and sucrose-exposed P and NP rats. J Neurophysiol 2011; 106:2606–2621.

▪. Díaz-Corpas T, Mateu-Puchades A, Morales-Suárez-Varela MM, Castells-Rodellas A. Retrospective study of patients diagnosed with Sweet syndrome in the health area of a tertiary hospital in the autonomous community of Valencia. Actas Dermosifiliogr 2012; 103:233–237. [90]

Dando R, Dvoryanchikov G, Pereira E, Chaudhari N, et al. Adenosine Enhances Sweet Taste through A2B Receptors in the Taste Bud. J Neurosci 2012; 32:322–330.

del Amor FM, Cuadra-Crespo P. Plant growth-promoting bacteria as a tool to improve salinity tolerance in sweet pepper. Funct Plant Biol 2012; 39:82–90.

Demoly P, Mertes M, Moneret-Vautrin AD, Michel FB. Contribution of epidemiology to the prevention of drug allergies. Bull Acad Natl Med 2011; 195:1335–1342.

Diernfellner ACR, Brunner M. O-GlcNAcylation of a circadian clock protein: dPER taking its sweet time. Genes Dev 2012; 26:415–416.

Elleuch E, Hammami B, Smaoui F, Maaloul I, et al. Sweet syndrome revealing leukemia. Arch Pediatr 2011; 18: 966–969.

Fearon ER. The sweet secrets of p27(kip1) regulation and function in cell migration Comment on: Nagano Y, et al. Cell Cycle 2011; 10:2593–2603Cell Cycle 2011; 10:3429–3430.

Finlayson G, Bordes I, Griffioen-Roose S, de Graaf C, et al. Susceptibility to Overeating Affects the Impact of Savory or Sweet Drinks on Satiation, Reward, and Food Intake in Nonobese Women. J Nutr 2012; 142:125–130.

Flight MH. ANTICANCER DRUGS A sweet blow for cancer cells. Nat Rev Immunol 2011; Drug Discovery. 10:734.

Freitas DFS, Valle ACF, Cuzzi T, Brandao LGP, et al. Sweet syndrome associated with sporotrichosis. Br J Dermatol 2012; 166:212–213.

Gan LJ, Yang D, Shin JA, Kim SJ, et al. Oxidative Comparison of Emulsion Systems from Fish Oil-Based Structured Lipid versus Physically Blended Lipid with Purple-Fleshed Sweet Potato (Ipomoea batatas L.) Extracts. J Agric Food Chem 2012; 60:467–475.

Giulino L, Guinan EC, Gillio AP, Drachtman RA, et al. Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease. Br J Haematol 2011; 154:278–281.

▪▪. Gray PE, Bock V, Ziegler DS, Wargon O. Neonatal Sweet syndrome: a potential marker of serious systemic illness. Pediatrics 2012; 129:e1353–e1359. [13]

Guan DL, Grau BL, Clark CA, Taylor CM, et al. Evidence That Thaxtomin C Is a Pathogenicity Determinant of Streptomyces ipomoeae, the Causative Agent of Streptomyces Soil Rot Disease of Sweet Potato. Mol Plant-Microbe Interact 2012; 25:393–401.

Haltiwanger RS, Feizi T. Glycobiology: the study of the sweet life. Curr Opin Struct Biol 2011; 21:573–575.

Hamann C, Kirschner S, Gunther KP, Hofbauer LC. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012; 8:297–305.

Han YT, Chen XH, Xie J, Zhan SM, et al. Purple Sweet Potato Pigments Scavenge ROS, Reduce p53 and Modulate Bcl-2/Bax to Inhibit Irradiation-induced Apoptosis in Murine Thymocytes. Cell Physiol Biochem 2011; 28:865–872.

Hann MM, Keseru GM. Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Rev Immunol 2012; Drug Discovery. 11:355–365.

Haraguchi K, Kawamoto A, Isami K, Maeda S, et al. TRPM2 Contributes to Inflammatory and Neuropathic Pain through the Aggravation of Pronociceptive Inflammatory Responses in Mice. J Neurosci 2012; 32:3931–3941.

He K, Ye XL, Li XG, Chen HY, et al. Separation of two constituents from purple sweet potato by combination of silica gel column and high-speed counter-current chromatography. J Chromatogr B 2012; 82:49–54.

He X, Galpin JD, Tropak MB, Mahuran D, et al. Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants. Glycobiology 2012; 22:492–503.

Hoff S, Lund MN, Petersen MA, Jespersen BM, et al. Influence of Malt Roasting on the Oxidative Stability of Sweet Wort. J Agric Food Chem 2012; 60:5652–5659.

Hofmann H, Pohlmann S. DC-SIGN: Access Portal for Sweet Viral Killers. Cell Host Microbe 2011; 10:5–7.

Hwang YP, Choi JH, Choi JM, Chung YC, et al. Protective mechanisms of anthocyanins from purple sweet potato against tert-butyl hydroperoxide-induced hepatotoxicity. Food Chem Toxicol 2011; 49:2081–2089.

Iwatsuki K, Ichikawa R, Uematsu A, Kitamura A, et al. Detecting sweet and umami tastes in the gastrointestinal tract. Acta Physiol 2012; 204:169–177.

Karna P, Gundala SR, Gupta MV, Shamsi SA, et al. Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo. Carcinogenesis 2011; 32:1872–1880.

Kashiwase K, Kobayashi H, Hirata A, Wada M, et al. Acute Changes in the Pacing Threshold After Lead Implantation Comparison Between Retractable and Sweet-Tip Active-Fixation Leads. Int Heart J 2012; 53:108–112.

▪▪. Keidel S, McColl A, Edmonds S. Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis. BMJ Case Rep. 2011; 2011. pii:bcr1020114935. [88]

Khan RS, Schulze PC, Bokhari S, Goldberg IJ. A sweet heart: Increased cardiac glucose uptake in patients with lipoprotein lipase deficiency. J Nucl Cardiol 2011; 18:1107–1110.

Kim MJ, Jang KT, Choe YH. Azathioprine Hypersensitivity Presenting as Sweet Syndrome in a Child with Ulcerative Colitis. Indian Pediatrics 2011; 48:969–971.

Krisanapun C, Lee SH, Peungvicha P, Temsiririrkkul R, et al. Antidiabetic Activities of Abutilon indicum (L.) Sweet AreMediated by Enhancement of Adipocyte Differentiation and Activation of the GLUT1 Promoter. Evid-based Complement Altern Med 2011.

Kulkarni G, Wadsworth WG. Hitting the sweet spot. Nat Methods 2012; 9:451–453.

Lian XJ, Li L, Zhang KS, Xu Y, et al. A new proposed sweet potato starch granule structure-Pomegranate concept. Int J Biol Macromol 2012; 50:471–475.

Lian XJ, Zhang KS, Luo QF, Zhang X, et al. The effects of electrolysis at room temperature on retrogradation of sweet potato starch. Int J Biol Macromol 2012; 50:38–42.

Lin JR, Zhang QA, Chen MH. Subcutaneous histiocytoid Sweet's syndrome in a patient associated with myelodysplastic syndrome-refractory anemia. J Dermatol 2012; 39:99–101.

Loney GC, Torregrossa AM, Carballo C, Eckel LA. Preference for Sucralose Predicts Behavioral Responses to Sweet and Bittersweet Tastants. Chem Senses 2012; 37:445–453.

Luczaj W, Stankiewicz-Kranc A, Milewska E, Roszkowska-Jakimiec W, et al. Effect of sweet grass extract against oxidative stress in rat liver and serum. Food Chem Toxicol 2012; 50:135–140.

Luo J. Cancer's sweet tooth for serine - art. no. 317. Breast Cancer Res 2011; 13:317.

Luo SL, Xu TY, Chen L, Chen JL, et al. Endophyte-assisted promotion of biomass production and metal-uptake of energy crop sweet sorghum by plant-growth-promoting endophyte Bacillus sp SLS18. Appl Microbiol Biotechnol 2012; 93:1745–1753.

▪▪. Ma EH, Akikusa JD, Macgregor D, et al. Sweet's syndrome with postinflammatory elastolysis and takayasu arteritis in a child: a case report and literature review. Pediatr Dermatol 2012; 29:645–650. [49]

Marchal A, Waffo-Teguo P, Genin E, Merillon JM, et al. Identification of New Natural Sweet Compounds in Wine Using Centrifugal Partition Chromatography-Gustatometry and Fourier Transform Mass Spectrometry. Anal Chem 2011; 83:9629–9637.

Martorell-Calatayud A, Requena C, Sanmartin O, Balmer N, et al. Gemcitabine-associated Sweet syndrome-like eruption. J Am Acad Dermatol 2011; 65:1236–1238.

Masuda T, Ohta K, Mikami B, Kitabatake N, et al. Atomic structure of the sweet-tasting protein thaumatin I at pH 8.0 reveals the large disulfide-rich region in domain II to be sensitive to a pH change. Biochem Biophys Res Commun 2012; 419:72–76.

Masuda T, Ohta K, Tani F, Mikami B, et al. Crystal structure of the sweet-tasting protein thaumatin II at 1.27 angstrom. Biochem Biophys Res Commun 2011; 410:457–460.

Mathieson C, Cresswell A. The Australian responds to Ray Moynihan and Melissa Sweet - art. no. d7725. Br Med J7725; 343:29..

Maturen KE, Kaza RK, Liu PS, Quint LE, et al. Sweet Spot'' for Endoleak Detection: Optimizing Contrast to Noise Using Low keV Reconstructions From Fast-Switch kVp Dual-Energy CT. J Comput Assist Tomogr 2012; 36:83–87.

Meinhardt C, Buning J, Fellermann K, Lehnert H, et al. Cyclophosphamide therapy in Sweet's syndrome complicating refractory Crohn's disease - Efficacy and mechanism of action. J Crohns Colitis 2011; 5:633–637.

Meyer V, Schneider SW, Bonsmann G, Beissert S. Experimentally Confirmed Induction of Sweet's Syndrome by Phototesting. Acta Derm-Venereol 2011; 91:720–721.

Modolon SD, Otsuka I, Fort S, Minatti E, et al. Sweet Block Copolymer Nanoparticles: Preparation and Self-Assembly of Fully Oligosaccharide-Based Amphiphile. Biomacromolecules 2012; 13:1129–1135.

Mohammadi M, Burbank L, Roper MC. Pantoea stewartii subsp stewartii Produces an Endoglucanase That Is Required for Full Virulence in Sweet Corn. Mol Plant-Microbe Interact 2012; 25:463–470.

Moran AP, Gupta A, Joshi L. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 2011; 60:1412–1425.

Naar AM. MiRs with a Sweet Tooth. Cell Metab 2011; 14:149–150.

Nakajima K, Koizumi A, Iizuka K, Ito K, et al. Non-Acidic Compounds Induce the Intense Sweet Taste of Neoculin, a Taste-Modifying Protein. Biosci Biotechnol Biochem 2011; 75:1600–1602.

O'Toole A, O'Malley M. Sweet Syndrome and Pemphigus Vulgaris. J Cutan Med Surg 2012; 16:128–130.

Ohta K, Masuda T, Tani F, Kitabatake N. Introduction of a negative charge at Arg82 in thaumatin abolished responses to human T1R2-T1R3 sweet receptors. Biochem Biophys Res Commun 2011; 413:41–45.

Okpul T, Harding RM, Dieters MJ, Godwin ID. Occurrence of LINE, gypsy-like, and copia-like retrotransposons in the clonally propagated sweet potato (Ipomoea batatas L.). Genome 2011; 54:603–609.

▪. Omoya K, Naiki Y, Kato Z, et al. Sweet's syndrome in a neonate with non-B54 types of human leukocyte antigen. World J Pediatr 2012; 8:181–184. [09]

Ozlem C, Deram B, Mustafa S, Koray T, et al. Propylthiouracil-induced Anti-neutrophil Cytoplasmic Antibodies and Agranulocytosis together with Granulocyte Colony-stimulating Factor Induced Sweet's Syndrome in a Patient with Graves' Disease. Intern Med 2011; 50:1973–1976.

Pan XQ, Zhang CL, Shi ZM. Soft drink and sweet food consumption and suicidal behaviours among Chinese adolescents. Acta Paediatr 2011; 100:E215–E222.

Parisky KM. Sweet meal proves too good to be true for caterpillars. J Exp Biol 2011; 214:V.

Park HD, Lee DH, Hong YH, Kang DH, et al. Three Korean Patients with Maple Syrup Urine Disease: Four Novel Mutations in the BCKDHA Gene. Ann Clin Lab Sci 2011; 41:167–173.

Park J, Kim S, Choi E, Kwak HR, et al. Molecular characterization of sweet potato leaf curl virus (SPLCV) isolates from Korea: phylogenetic relationship and recombination analysis. Acta Virol 2011; 55:327–335.

Poulaert M, Borel P, Caporiccio B, Gunata Z, et al. Grapefruit Juices Impair the Bioaccessibility of beta-Carotene from Orange-Fleshed Sweet Potato but Not Its Intestinal Uptake by Caco-2 Cells. J Agric Food Chem 2012; 60:685–691.

Qazi HA, Paranjpe S, Bhargava S. Stem sugar accumulation in sweet sorghum - Activity and expression of sucrose metabolizing enzymes and sucrose transporters. J Plant Physiol 2012; 169:605–613.

Rantsiou K, Dolci P, Giacosa S, Torchio F, et al. Candida zemplinina Can Reduce Acetic Acid Produced by Saccharomyces cerevisiae in Sweet Wine Fermentations. Appl Environ Microbiol 2012; 78:1987–1994.

Rappuoli R, De Gregorio E. A sweet T cell response. Nat Med 2011; 17:1551–1552.

Riske F, Hamilton A, Zhang C, Hayes M. Remodeling the oligosaccharides on beta-glucocerebrosidase using hydrophobic interaction chromatography and applications of hydroxyl ethyl starch for improving remodeling and enhancing protein stability. Biotechnol Bioeng 2012; 109:1217–1227.

▪▪. Rochael MC, Pantaleão L, Vilar EA, et al. Sweet's syndrome: study of 73 cases, emphasizing histopathological findings. An Bras Dermatol 2011; 86:702–707. [33]

Romero P, Rodrigo MJ, Alferez F, Ballester AR, et al. Unravelling molecular responses to moderate dehydration in harvested fruit of sweet orange (Citrus sinensis L. Osbeck) using a fruit-specific ABA-deficient mutant. J Exp Bot 2012; 63:2753–2767.

Rosales R, Burns JK. Phytohormone Changes and Carbohydrate Status in Sweet Orange Fruit from Huanglongbing-infected Trees. J Plant Growth Regul 2011; 30:312–321.

Ross SM. Sweet Dreams. Holist Nurs Pract 2010; 24:238–240.

Roullier C, Rossel G, Tay D, McKey D, et al. Combining chloroplast and nuclear microsatellites to investigate origin and dispersal of New World sweet potato landraces. Mol Ecol 2011; 20:3963–3977.

Saidi H, Shojaie S. Effect of sweet almond oil on survival rate and plasma cholinesterase activity of aluminum phosphide-intoxicated rats. Hum Exp Toxicol 2012; 31:518–522.

Sancho-Martinez I, Nivet E, Belmonte JCI. Purging and isolating pluripotent cells, ‘‘sweet’' dreams become true? Cell Res 2011; 21:1526–1527.

Santini D, Vincenzi B, Pantano F, Tonini G, et al. Targeting bone metastases starting from the preneoplastic niche: home sweet home - art. no. 111. Breast Cancer Res 2011; 13:111.

Sarropoulou VN, Therios IN, Dimassi-Theriou KN. Melatonin promotes adventitious root regeneration in in vitro shoot tip explants of the commercial sweet cherry rootstocks CAB-6P (Prunus cerasus L.), Gisela 6 (P. cerasus P. canescens), and MxM 60 (P. avium P. mahaleb). J Pineal Res 2012; 52:38–46.

Sartor F, Donaldson LF, Markland DA, Loveday H, et al. Taste perception and implicit attitude toward sweet index and soft drink supplementation. Appetite 2011; 57:237–246.

▪. Schadt CR, Callen JP. Management of neutrophilic dermatoses. Dermatol Ther 2012; 25:158–172. [63]

Schmitz G, Tibbles C. Genitourinary Emergencies in the Nonpregnant Woman. Emerg Med Clin N Am 2011; 29:621.

Sepehr A, Tahan SR. ''Nevus/Melanocytoma/Melanoma‘‘: That Which We Call a Rose by Any Other Name Would Smell as Sweet. Arch Pathol Lab Med 2012; 136:135.

Shen F, Saddler JN, Liu RH, Lin LL, et al. Evaluation of steam pretreatment on sweet sorghum bagasse for enzymatic hydrolysis and bioethanol production. Carbohydr Polym 2011; 86:1542–1548.

Shen F, Zhong YH, Saddler JN, Liu RH. Relatively High-Substrate Consistency Hydrolysis of Steam-Pretreated Sweet Sorghum Bagasse at Relatively Low Cellulase Loading. Appl Biochem Biotechnol 2011; 165:1024–1036.

▪. Shugarman IL, Schmit JM, Sbicca JA, Wirk B. Easily missed extracutaneous manifestation of malignancy-associated Sweet's syndrome: systemic inflammatory response syndrome. J Clin Oncol 2011; 29:e702–e705. [31]

Shugarman IL, Schmit JM, Sbicca JA, Wirk B. Easily Missed Extracutaneous Manifestation of Malignancy-Associated Sweet's Syndrome: Systemic Inflammatory Response Syndrome. J Clin Oncol 2011; 29:E702–E705.

Spetter MS, de Graaf C, Viergever MA, Smeets PAM. Anterior Cingulate Taste Activation Predicts Ad Libitum Intake of Sweet and Savory Drinks in Healthy, Normal-Weight Men. J Nutr 2012; 142:795–802.

Talevi A, Enrique AV, Bruno-Blanch LE. Anticonvulsant activity of artificial sweeteners: A structural link between sweet-taste receptor T1R3 and brain glutamate receptors. Bioorg Med Chem Lett 2012; 22:4072–4074.

Theodore M, Morava E. Congenital disorders of glycosylation: sweet news. Curr Opin Pediatr 2011; 23:581–587.

Tomonari H, Miura H, Nakayama A, Matsumura E, et al. G alpha-gustducin Is Extensively Coexpressed with Sweet and Bitter Taste Receptors in both the Soft Palate and Fungiform Papillae but Has a Different Functional Significance. Chem Senses 2012; 37:241–251.

Turra C, Fernandes EAD, Bacchi MA, Barbosa F, et al. Chemical Elements in Organic and Conventional Sweet Oranges. Biol Trace Elem Res 2011; 144:1289–1294.

Uihlein LC, Brandling-Bennett HA, Lio PA, Liang MG. Sweet Syndrome in Children. Pediatr Dermatol 2012; 29:38–44.

Van Loon K, Gill RM, McMahon P, Chigurupati R, et al. 20q-Clonality in a Case of Oral Sweet Syndrome and Myelodysplasia. Am J Clin Pathol 2012; 137:310–315.

Vergier B. Cutaneous neutrophils infiltrates. Case 6. Neutrophilic dermatosis (Sweet syndrome) with atypical “blast-like” cells. Ann Pathol 2011; 31:194–197.

Wang D, Wang XR, Zhang C, Ma Y, et al. Calf Thymus DNA-Binding Ability Study of Anthocyanins from Purple Sweet Potatoes (Ipomoea batatas L.). J Agric Food Chem 2011; 59:7405–7409.

Ward SJ, Rasmussen BA, Corley G, Henry C, et al. Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behav Pharmacol 2011; 22:370–373.

▪. Wojcik AS, Nishimori FS, Santamaría JR. Sweet's syndrome: a study of 23 cases. An Bras Dermatol 2011; 86:265–271. [04]

Wu TZ, Zhao BR, Bound MJ, Checklin HL, et al. Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans. Am J Clin Nutr 2012; 95:78–83.

Yang S, Tang XF, Ma NN, Wang LY, et al. Heterology expression of the sweet pepper CBF3 gene confers elevated tolerance to chilling stress in transgenic tobacco. J Plant Physiol 2011; 168:1804–1812.

Zeng YL, Pan ZY, Ding YD, Zhu AD, et al. A proteomic analysis of the chromoplasts isolated from sweet orange fruits. J Exp Bot 2011; 62:5297–5309.

Zhang GH, Chen ML, Liu SS, Zhan YH, et al. Effects of Mother's Dietary Exposure to Acesulfame-K in Pregnancy or Lactation on the Adult Offspring's Sweet Preference. Chem Senses 2011; 36:763–770.

Zheng LY, Guo XS, He B, Sun LJ, et al. Genome-wide patterns of genetic variation in sweet and grain sorghum (Sorghum bicolor) - art. no. R114. Genome Biol 2011; 12:R114.

Zwart M. The sweet memories of a fruit fly. J Exp Biol 2011;214:III.

Haematological features in Barth syndrome

Review: (pp. 36–40)

▪. Acehan D, Vaz F, Houtkooper RH, James J, et al. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 2011; 286:899–908. [14]

Bain BJ. Haemoglobinopathy diagnosis: Algorithms, lessons and pitfalls. Blood Rev 2011; 25:205–213.

Castagnola E, Garre ML, Bertoluzzo L, Pignatelli S, et al. Epidemiology of Febrile Neutropenia in Children With Central Nervous System Tumor: Results From a Single Center Prospective Study. J Pediatr Hematol Oncol 2011; 33:E310–E315.

Chiarello C, Halderman L, Welcome SE, Leonard CM. Does degree of asymmetry relate to performance? A reply to Boles and Barth. Brain Cogn 2011; 77:135–137.

▪. Cosson L, Toutain A, Simard G, et al. Barth syndrome in a female patient. Mol Genet Metab 2012; 106:115–120. [01]

Dierickx D, Cortoos A, Van derschueren S. The haemophagocytic syndrome. Acta Clin Belg 2011; 66:448–452.

Erduran E, Zaman T, Deger O, Tekelioglu Y, et al. In Vitro Determination of Apoptotic Effect of Heparin on Lymphoblasts By Using Flow Cytometric DNA Analysis and Measurements of Caspase-9 Activation and Cytochrome C Level. J Pediatr Hematol Oncol 2012; 34:E26–E29.

Givol N, Goldstein G, Peleg O, Shenkman B, et al. Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease. Haemophilia 2012; 18:117–121.

Gupta S, Bonilla M, Gamero M, Fuentes SL, et al. Microbiology and Mortality of Pediatric Febrile Neutropenia in El Salvador. J Pediatr Hematol Oncol 2011; 33:276–280.

▪. Makaryan V, Kulik W, Vaz FM, et al. The cellular and molecular mechanisms for neutropenia in Barth syndrome. Eur J Haematol 2012; 88:195–209. [13]

Naidus E, Damon L, Schwartz BS, Breed C, et al. Experience with use of Zostavax (R) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol 2012; 87:123–125.

Raches D, Mazzocco MMM. Emergence and Nature of Mathematical Difficulties in Young Children with Barth Syndrome. J Dev Behav Pediatr 2012; 33:328–335.

Vanska M, Koivula I, Hamalainen S, Pulkki K, et al. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematol-Hematol J 2011; 96:1385–1389.

Wu P, Morey TE, Harris NS, Gravenstein N, et al. Intravenous Fluids Cause Systemic Bias in a Conductivity-Based Point-of-Care Hematocrit Meter. Anesth Analg 2012; 114:314–321.

Haematological manifestations and complications of Gaucher disease

Review: (pp. 41–47)

Abian O, Alfonso P, Velazquez-Campoy A, Giraldo P, et al. Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase. Mol Pharm 2011; 8:2390–2397.

Akdag A, Oguz SS, Ezgu F, Erdeve O, et al. A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene. J Pediatr Endocrinol Metab 2011; 24:381–383.

Arikan-Ayyildiz Z, Yuce A, Uslu-Kizilkan N, Demir H, et al. Hyperimmunoglobulinemia in pediatric patients with Gaucher disease in Southern Brazil. Pediatr Blood Cancer 2012; 59:340.

Bain BJ. Haemoglobinopathy diagnosis: Algorithms, lessons and pitfalls. Blood Rev 2011; 25:205–213.

Baris HN, Raas-Rothschild A, Garty BZ, Tor R, et al. Gaucher disease type 2-Homozygosity for the mutation F331S in two unrelated consanguineous Muslim Arab patients with Gaucher disease from the Gaza and Jenin regions. Blood Cells Mol Dis 2011; 47:262–263.

Berger J, Stirnemann J, Bourgne C, Pereira B, et al. The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable. Br J Haematol 2012; 157:274–277.

Bruscolini A, Pirraglia MP, Restivo L, Spinucci G, et al. A branch retinal artery occlusion in a patient with Gaucher disease. Graefes Arch Clin Exp Ophthalmol 2012; 250:441–444.

Camou F, Viallard JF. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy. Blood Cells Mol Dis 2012; 48:51–52.

▪. Cha JR, Kim SJ, Heo TH. Protective effect of recombinant human erythropoietin in type II Gaucher disease patient cells by scavenging endoplasmic reticulum stress. Biomed Pharmacother 2011; 65:364–368. [19]

Cha JR, Kim SJ, Heo TH. Protective effect of recombinant human erythropoietin in type II Gaucher disease patient cells by scavenging endoplasmic reticulum stress. Biomed Pharmacother 2011; 65:364–368.

Chan A, Holleran WM, Ferguson T, Crumrine D, et al. Skin ultrastructural findings in type 2 Gaucher disease: Diagnostic implications. Mol Genet Metab 2011; 104:631–636.

Cookson MR. A Feedforward Loop Links Gaucher and Parkinson's Diseases? Cell 2011; 146:9–11.

▪. Deegan PB, Pavlova E, Tindall J, et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore) 2011; 90:52–60. [48]

▪. Dekker N, van Dussen L, Hollak CE, et al. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 2011; 118:e118–e127. [50]

Dekker N, van Dussen L, Hollak CEM, Overkleeft H, et al. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 2011; 118:E118–E127.

Dierickx D, Cortoos A, Van derschueren S. The haemophagocytic syndrome. Acta Clin Belg 2011; 66:448–452.

Diot JD, Moreno IG, Twigg G, Mellet CO, et al. Amphiphilic 1-Deoxynojirimycin Derivatives through Click Strategies for Chemical Chaperoning in N370S Gaucher Cells. J Org Chem 2011; 76:7757–7768.

Donaldson J, Khan WS, Tailor H, Hughes DA, et al. Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. Hip Int 2011; 21:665–671.

Elstein D, Altarescu G, Maayan H, Phillips M, et al. Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem. Blood Cells Mol Dis 2012; 48:45–50.

▪. Givol N, Goldstein G, Peleg O, et al. Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease. Haemophilia 2012; 18:117–121. [25]

Givol N, Goldstein G, Peleg O, Shenkman B, et al. Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease. Haemophilia 2012; 18:117–121.

▪. Hollak CE, Belmatoug N, Cole JA, et al. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years. Br J Haematol 2012; 158:528–538. [16]

Jovic M, Kean MJ, Szentpetery Z, Polevoy G, et al. Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase. Mol Biol Cell 2012; 23:1533–1545.

▪▪. Khan A, Hangartner T, Weinreb NJ, et al. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. J Bone Miner Res 2012; 27:1839–1848. [29]

Lee YJ, Kim SJ, Heo TH. Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress. Biochem Biophys Res Commun 2011; 413:254–258.

Lo SM, Choi M, Liu J, Jain D, et al. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis. Blood 2012; 119:4731–4740.

▪▪. Mazzulli JR, Xu YH, Sun Y, et al. Gaucher disease glucocerebrosidase and a-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011; 146:37–52. [40]

Mazzulli JR, Xu YH, Sun Y, Knight AL, et al. Gaucher Disease Glucocerebrosidase and alpha-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies. Cell 2011; 146:37–52.

McNeill A, Duran R, Proukakis C, Bras J, et al. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord 2012; 27:526–532.

Mekinian A, Stirnemann J, Belmatoug N, Heraoui D, et al. Ferritinemia during type 1 Gaucher disease: Mechanisms and progression under treatment. Blood Cells Mol Dis 2012; 49:53–57.

Mikosch P. Gaucher disease and bone. Best Pract Res Clin Rheumatol 2011; 25:665–681.

Mitrovic M, Sumarac Z, Antic D, Bogdanovic A, et al. Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy. Blood Cells Mol Dis 2012; 49:58–59.

Nagral A, Mewawalla P, Jagadeesh S, Kabra M, et al. Recombinant Macrophage Targeted Enzyme Replacement Therapy for Gaucher Disease in India. Indian Pediatrics 2011; 48:779–784.

Naidus E, Damon L, Schwartz BS, Breed C, et al. Experience with use of Zostavax (R) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol 2012; 87:123–125.

Orwig SD, Tan YL, Grimster NP, Yu ZQ, et al. Binding of 3,4,5,6-Tetrahydroxyazepanes to the Acid-beta-glucosidase Active Site: Implications for Pharmacological Chaperone Design for Gaucher Disease. Biochemistry 2011; 50: 10647–10657.

Paz Z, Nalls M, Ziv E. The Genetics of Benign Neutropenia. Isr Med Assoc J 2011; 13:625–629.

Saranjam HR, Sidransky E, Levine WZ, Zimran A, et al. Mandibular and dental manifestations of Gaucher disease. Oral Dis 2012; 18:421–429.

Sellos-Moura M, Barzegar S, Pan LY, Shi P, et al. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease. J Immunol Methods 2011; 373:45–53.

Sun Y, Liou B, Xu YH, Quinn B, et al. Ex Vivo and in Vivo Effects of Isofagomine on Acid beta-Glucosidase Variants and Substrate Levels in Gaucher Disease. J Biol Chem 2012; 287:4275–4287.

Trapero A, Llebaria A. The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease. ACS Med Chem Lett 2011; 2:614–619.

Traynor K. Taliglucerase alfa approved for Gaucher disease. Am J Health-Syst Pharm 2012; 69:1009.

Vairo F, Alegra T, Dornelles A, Mittelstadt S, et al. Hyperimmunoglobulinemia in pediatric Gaucher patients in Southern Brazil. Pediatr Blood Cancer 2012; 59:339.

van Dussen L, Lips P, Everts VE, Bravenboer N, et al. Markers of Bone Turnover in Gaucher Disease: Modeling the Evolution of Bone Disease. J Clin Endocrinol Metab 2011; 96:2194–2205.

Van Sweringen HL, Sakai N, Tevar AD, Burns JM, et al. CXC Chemokine Signaling in the Liver: Impact on Repair and Regeneration. Hepatology 2011; 54:1445–1453.

Velayati A, De Paolo J, Gupta N, Choi JH, et al. A Mutation in SCARB2 is a Modifier in Gaucher Disease. Hum Mutat 2011; 32:1232–1238.

Yap TL, Gruschus JM, Velayati A, Westbroek W, et al. alpha-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases. J Biol Chem 2011; 286:28080–28088.

▪▪. Zhang CK, Stein PB, Liu J, et al. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am J Hematol 2012; 87:377–383. [03]

Zimran A. How I treat Gaucher disease. Blood 2011; 118:1463–1471.

Zimran A. Velaglucerase alfa: a new option for gaucher disease treatment. Drugs Today 2011; 47:515–529.

Zimran A, Brill-Almon E, Chertkoff R, Petakov M, et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 2011; 118:5767–5773.

Guidelines for newborn screening of primary immunodeficiency diseases

Review: (pp. 48–54)

Aizire J, Fowler MG, Wang J, Shetty AK, et al. Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. Aids 2012; 26:325–333.

Al Hajjar S, Al Thawadi S, Al Seraihi A, Al Muhsen S, et al. Human metapneumovirus and human coronavirus infection and pathogenicity in Saudi children hospitalized with acute respiratory illness. Ann Saudi Med 2011; 31:523–527.

Ariga T. Wiskott-Aldrich Syndrome; An X-Linked Primary Immunodeficiency Disease with Unique and Characteristic Features. Allergol Int 2012; 61:183–189.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, et al. Altered T cell responses in children with autism. Brain Behav Immun 2011; 25:840–849.

▪. Borte S, von Döbeln U, Fasth A, et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012; 119: 2552–2555. [05]

▪. Brown L, Xu-Bayford J, Allwood Z, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 2011; 117:3243–3246. [03]

Cetinkaya S, Kara C. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2011; 24:265–269.

▪. Chan K, Davis J, Pai SY, et al. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab 2011; 104:383–389. [26]

Critchfield JW, van Hemert S, Ash M, Mulder L, et al. The Potential Role of Probiotics in the Management of Childhood Autism Spectrum Disorders - art. no. 161358. Gastroenterol Res Pract 2011; 61358.

Danen-van Oorschot AA, Kuipers JE, Arentsen-Peters S, Schotte D, et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer 2012; 58:715–721.

Dehkordy SF, Aghamohammadi A, Ochs HD, Rezaei N. Primary Immunodeficiency Diseases Associated with Neurologic Manifestations. J Clin Immunol 2012; 32:1–24.

Dobros W, Burda K, Guzik K, Koziel J, et al. Apoptotic cell clearance in chronic inflammation of lateral neck cysts. Eur Arch Oto-Rhino-Laryn 2012; 269:965–970.

Doni SN, Mitchell AL, Bogale Y, Walker SL. Skin disorders affecting human immunodeficiency virus-infected children living in an orphanage in Ethiopia. Clin Exp Dermatol 2012; 37:15–19.

Freund L, Hintermair M. Pregnant women's expectations concerning universal newborn hearing screening. Hno 2012; 60:337–342.

Gray PEA, Namasivayam M, Ziegler JB. Recurrent infection in children: When and how to investigate for primary immunodeficiency? J Paediatr Child Health 2012; 48:202–209.

Haile-Selassie HT, Townsend CL, Tookey PA. Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001–2008. HIV Med 2011; 12:422–427.

Hamidieh AA, Pourpak Z, Hosseinzadeh M, Fazlollahi MR, et al. Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism. Bone Marrow Transplant 2012; 47:646–650.

Jarrasse C, Pagnier A, Edan C, Landman-Parker J, et al. Hodgkin disease and autoimmunity in children: 11 case reports. Arch Pediatr 2011; 18:376–382.

Kasasbeh A, Hwang EC, Steger-May K, Bandt SK, et al. Association of magnetic resonance imaging identification of mesial temporal sclerosis with pathological diagnosis and surgical outcomes in children following epilepsy surgery Clinical article. J Neurosurg-Pediatr 2012; 9:552–561.

Kiguchi N, Kobayashi Y, Maeda T, Fukazawa Y, et al. Epigenetic Augmentation of the Macrophage Inflammatory Protein 2/C-X-C Chemokine Receptor Type 2 Axis through Histone H3 Acetylation in Injured Peripheral Nerves Elicits Neuropathic Pain. J Pharmacol Exp Ther 2012; 340:577–587.

Kladny B, Williams A, Gupta A, Gettig EA, et al. Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety. Genet Med 2011; 13:658–661.

Koumans EHA, Rosen J, van Dyke MK, Zell E, et al. Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004 - art. no. 158.e1. Am J Obstet Gynecol 2012; 206:E1.

Krebs A, Schmidt-Trucksass A, Doerfer J, Grulich-Henn J, et al. Cardiovascular risk in pediatric type 1 diabetes: sex-specific intima-media thickening verified by automatic contour identification and analyzing systems. Pediatr Diabetes 2012; 13:251–258.

Kress DW. Pediatric dermatology emergencies. Curr Opin Pediatr 2011; 23:403–406.

Lachmann RH. Enzyme replacement therapy for lysosomal storage diseases. Curr Opin Pediatr 2011; 23:588–593.

Lefevre F, Moreau D, Semon E, Kalaboka S, et al. Maternal depression related to infant's wheezing. Pediatr Allergy Immunol 2011; 22:608–613.

▪. Loeber G, Burgard P, Cornel M, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2: from screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis 2012; 35:613–625. [12]

▪. Meeths M, Chiang SC, Wood SM, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood 2011; 118:5783–5793. [04]

Munck A, Roussey M. Cystic fibrosis newborn screening: management issues. Arch Pediatr 2012; 19:S30–S32.

Novince CM, Koh AJ, Michalski MN, Marchesan JT, et al. Proteoglycan 4, a Novel Immunomodulatory Factor, Regulates Parathyroid Hormone Actions on Hematopoietic Cells. Am J Pathol 2011; 179:2431–2442.

Ochtrop MLG, Goldacker S, May AM, Rizzi M, et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011; 118:309–318.

Parikh S, Bessler M. Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr 2012; 24:23–32.

▪▪. Petros M. Revisiting the Wilson–Jungner criteria: how can supplemental criteria guide public health in the era of genetic screening? Genet Med 2012; 14:129–134. [14]

Prak ETL, Ross J, Sutter J, Sullivan KE. Age-Related Trends in Pediatric B-Cell Subsets. Pediatr Dev Pathol 2011; 14:45–52.

▪. Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol 2012; 129:607–616. [22]

Puck JM. Neonatal screening for severe combined immunodeficiency. Curr Opin Pediatr 2011; 23:667–673.

Quentien MH, Delemer B, Papadimitriou DT, Souchon PF, et al. Deficit in Anterior Pituitary Function and Variable Immune Deficiency (DAVID) in Children Presenting with Adrenocorticotropin Deficiency and Severe Infections. J Clin Endocrinol Metab 2012; 97:E121–E128.

▪▪. Speckmann C, Neumann C, Borte S, et al. Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis. J Allergy Clin Immunol 2012; 130:991–994. [24]

Tabuchi T, Che XF, Hiraishi K, Adachi M, et al. Selectively Induced Apoptosis in Human Neutrophils in the Presence of Oxidative Phenoxazines, 2-Amino-4,4 alpha-dihydryo-4 alpha-7H-phenoxazine-3-one and 2-Aminophenoxazine-3-one, Preceded by Decrease of Intracellular pH, Depolarization of the Mitochondria, and Inhibition of Superoxide Generation. J Pharmacol Sci 2011; 117:139–148.

Thornton NL, Cody MJ, Yost CC. Toll-Like Receptor 1/2 Stimulation Induces Elevated Interleukin-8 Secretion in Polymorphonuclear Leukocytes Isolated from Preterm and Term Newborn Infants. Neonatology 2012; 101:140–146.

Vansenne F, de Borgie C, Legdeur M, Spauwen MO, et al. Providing Genetic Risk Information to Parents of Newborns with Sickle Cell Trait: Role of the General Practitioner in Neonatal Screening. Genet Test Mol Biomark 2011; 15:671–675.

▪. Verbsky J, Thakar M, Routes J. The Wisconson approach to newborn screening for severe combined immunodeficiency. J Alergy Clin Imunol 2012; 129:622–627. [19]

Verbsky J, Thakar M, Routes J. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2012; 129:622–627.

Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, et al. Newborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008–2011). J Clin Immunol 2012; 32:82–88.

Wagener JS, Zemanick ET, Sontag MK. Newborn screening for cystic fibrosis. Curr Opin Pediatr 2012; 24:329–335.

Walkovich K, Boxer LA. Congenital neutropenia in a newborn. J Perinatol 2011; 31:S22–S23.

Neutropenia in primary immunodeficiency

Review: (pp. 55–65)

▪. Abdollahpour H, Appaswamy G, Kotlarz D, et al. The phenotype of human STK4 deficiency. Blood 2012; 119:3450–3457. [35]

Agrawal AK, Saini N, Gildengorin G, Feusner JH. Is Routine Computed Tomographic Scanning Justified in the First Week of Persistent Febrile Neutropenia in Children With Malignancies? Pediatr Blood Cancer 2011; 57:620–624.

▪▪. Al-Herz W, Bousfiha A, Casanova J-L, et al. Primary immunodeficiency diseases: an update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol 2011; 2:1–26. [01]

Audrain M, Martin J, Fromont P, Prie N, et al. Autoimmune neutropenia in children: analysis of 116 cases. Pediatr Allergy Immunol 2011; 22:494–496.

Badurdeen S, Hodge G, Osborn M, Scott J, et al. Elevated Serum Cytokine Levels Using Cytometric Bead Arrays Predict Culture-Positive Infections in Childhood Oncology Patients With Febrile Neutropenia. J Pediatr Hematol Oncol 2012; 34:E36–E38.

▪. Banka S, Chervinsky E, Newman WG, et al. Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. Eur J Hum Genet 2011; 19:18–22. [61]

Black E, Lau TTY, Ensom MHH. Vancomycin-Induced Neutropenia: Is it Dose- or Duration-Related? Ann Pharmacother 2011; 45:629–638.

Bourgeois GP, Cafardi JA, Groysman V, Pamboukian SV, et al. Fulminant myocarditis as a late sequela of DRESS: Two cases. J Am Acad Dermatol 2011; 65:889–890.

Bow EJ. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients. Curr Opin Infect Dis 2011; 24:545–553.

▪▪. Boztug K, Rosenberg PS, Dorda M, et al. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 2012; 160:679–683. e672 [08]

Breccia M, Loglisci G, Salaroli A, Finsinger P, et al. Neutropenia at baseline could indicate poor prognosis in low/intermediate risk myelodysplastic syndrome patients. Leuk Res 2012; 36:546–547.

▪▪. Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res 2011; 49:25–43. [99]

▪. Carlsson G, Fasth A, Berglöf E, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Br J Haematol 2012; 158:363–369. [03]

Chung C, Tumeh PC, Birnbaum R, Tan BH, et al. Characteristic purpura of the ears, vasculitis, and neutropenia-a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 2011; 65:722–725.

▪. Colombo EA, Bazan JF, Negri G, et al. Novel C16orf57 mutations in patients with poikiloderma with neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutations. Orphanet J Rare Dis 2012; 7:7. [68]

Confavreux CB, Canoui-Poitrine F, Schott AM, Ambrosi V, et al. Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database. Eur J Endocrinol 2012; 166:735–741.

Cooper MR, Durand CR, Beaulac MT, Steinberg M. Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia. Ann Pharmacother 2011; 45:1094–1102.

Cordoba I, Gonzalez-Porras JR, Such E, Nomdedeu B, et al. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leuk Res 2012; 36:287–292.

▪▪. Dale DC, Bolyard AA, Kelley ML, et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 2011; 118:4963–4966. [48]

Desai A, Gopalkrishnan K, Joshi VK, Rao CB. Cyclic Neutropenia in a Cleft Lip and Palate Patient: A Case Report. Cleft Palate-Craniofac J 2011; 48:776–778.

Donahue RE, Tuschong L, Bauer TR, Yau YY, et al. Leukocyte integrin activation mediates transient neutropenia after G-CSF administration. Blood 2011; 118:4209–4214.

▪. Doncker AV, Balabanian K, Bellanné-Chantelot C, et al. Two cases of disseminated Mycobacterium avium infection associated with a new immunodeficiency syndrome related to CXCR4 dysfunctions. Clin Microbiol Infect 2011; 17:135–139. [75]

Fioredda F, Calvillo M, Bonanomi S, Coliva T, et al. Congenital and Acquired Neutropenia Consensus Guidelines on Diagnosis From the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Pediatr Blood Cancer 2011; 57:10–17.

▪▪. Fioredda F, Calvillo M, Bonanomi S, et al. Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Pediatr Blood Cancer 2011; 57:10–17. [83]

Frakking FNJ, Israels J, Kremer LCM, Kuijpers TW, et al. Mannose-Binding Lectin (MBL) and the Risk for Febrile Neutropenia and Infection in Pediatric Oncology Patients With Chemotherapy. Pediatr Blood Cancer 2011; 57:89–96.

Gascon P, Aapro M, Ludwig H, Rosencher N, et al. Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim. Crit Rev Oncol/Hematol 2011; 77:184–197.

Gascon P, Aapro M, Ludwig H, Rosencher N, et al. Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments. Crit Rev Oncol/Hematol 2011; 77:198–200.

Han YW, Yu ZH, Wen SY, Zhang B, et al. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer. Breast Cancer Res Treat 2012; 131:483–490.

▪. Hayee B, Antonopoulos A, Murphy EJ, et al. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology 2011; 21:914–924. [66]

Hendricks AM, Loggers ET, Talcott JA. Costs of Home Versus Inpatient Treatment for Fever and Neutropenia: Analysis of a Multicenter Randomized Trial. J Clin Oncol 2011; 29:3984–3989.

Hochart C, Berthon C, Corm S, Gay J, et al. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia. Med Mal Infect 2011; 41:652–656.

Hwang K, Park CJ, Huh HJ, Han SH, et al. Flow Cytometric Detection of Neutrophil-associated Immunoglobulin in Patients with or without Neutropenia and Establishment of the Reference Interval. Ann Clin Lab Sci 2011; 41:144–149.

Ichikawa M, Suzuki D, Ohshima J, Cho Y, et al. Piperacillin/Tazobactam Versus Cefozopran for the Empirical Treatment of Pediatric Cancer Patients With Febrile Neutropenia. Pediatr Blood Cancer 2011; 57:1159–1162.

Janssen-Heijnen MLG, Extermann M, Boler IE. Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy? Crit Rev Oncol/Hematol 2011; 79:43–50.

Jones C, Denecke J, Strater R, Stolting T, et al. A Novel Type of Macrothrombocytopenia Associated with a Defect in alpha 2,3-Sialylation. Am J Pathol 2011; 179:1969–1977.

▪. Jun HS, Lee YM, Song KD, et al. G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis. Blood 2011; 117:3881–3892. [65]

Klastersky J, Awada A. Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice? Crit Rev Oncol/Hematol 2011; 78:17–23.

Klastersky J, Awada A, Paesmans M, Aoun M. Febrile neutropenia: A critical review of the initial management. Crit Rev Oncol/Hematol 2011; 78:185–194.

Kouranos V, Dimopoulos G, Vassias A, Syrigos KN. Chemotherapy-induced neutropenia in lung cancer patients: The role of antibiotic prophylaxis. Cancer Lett 2011; 313:9–14.

Kurnikova M, Maschan M, Dinova E, Shagina I, et al. Four Novel ELANE Mutations in Patients With Congenital Neutropenia. Pediatr Blood Cancer 2011; 57:332–335.

▪. Liu Q, Chen H, Ojode T, et al. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood 2012; 120:181–189. [74]

Lyons RM, Wilks ST, Young S, Brown GL. Oral ezatiostat HCl (Telintra (R), TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor - art. no. 43. J Hematol Oncol 2011; 4:2.

Martorell-Calatayud A, Requena C, Sanmartin O, Balmer N, et al. Gemcitabine-associated Sweet syndrome-like eruption. J Am Acad Dermatol 2011; 65:1236–1238.

McCavit TL, Winick N. Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: A survey of pediatric oncology centers. Pediatr Blood Cancer 2012; 58:303–305.

▪▪. McDermott DH, Liu Q, Ulrick J, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 2011; 118:4957–4962. [49]

▪. McDermott DH, Lopez J, Deng F, et al. AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. J Cell Mol Med 2011; 15:2071–2081. [72]

▪. Nehme NT, Schmid JP, Debeurme F, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 2012; 119:3458–3468. [36]

Ng JH, Ang XY, Tan SH, Tao M, et al. Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin's Lymphoma Patients Receiving Pegfilgrastim. Acta Haematol 2011; 125:107–114.

Ozdemir N, Celkan T, Baris S, Batar B, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of febrile neutropenia and mucositis in children with leukemia and lymphoma. Leuk Res 2012; 36:565–569.

Pasek TA, Huber JM. Hospitalized Infants Who Hurt: A Sweet Solution With Oral Sucrose. Crit Care Nurse 2012; 32:61–69.

Pavlaki KI, Kastrinaki MC, Klontzas M, Velegraki M, et al. Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia. Haematol-Hematol J 2012; 97:743–750.

Paz Z, Nalls M, Ziv E. The Genetics of Benign Neutropenia. Isr Med Assoc J 2011; 13:625–629.

Pechter PM, Marchione R, Milikowski C, Berman B. Ecthyma Gangrenosum Secondary to Staphylococcus aureus in an Infant with Transient Neutropenia. Pediatr Dermatol 2012; 29:320–323.

Petrini M, Azzara A. Lithium in the treatment of neutropenia. Curr Opin Hematol 2012; 19:52–57.

Phippen NT, Lowery WJ, Barnett JC, Hall LA, et al. Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: A pilot study. Gynecol Oncol 2011; 123: 360–364.

▪. Rizzi M, Neumann C, Fielding AK, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 2011; 128:1371–1374. e1372 [44]

Saloustros E, Tryfonidis K, Georgoulias V. Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia. Expert Opin Pharmacother 2011; 12:851–863.

Sandoval C, Sinaki B, Weiss R, Munoz J, et al. Urinary Tract Infections in Pediatric Oncology Patients with Fever and Neutropenia. Pediatr Hematol Oncol 2012; 29:68–72.

Schmidmaier R, Then C, Schnabel B, Oduncu F, et al. CD4(+) CD28(+) lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft. Cytotherapy 2011; 13:987–992.

Shitara K, Matsuo K, Oze I, Mizota A, et al. Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy. Cancer Chemother Pharmacol 2011; 68:301–307.

Soto E, Keizer RJ, Troconiz IF, Huitema ADR, et al. Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies. Invest New Drugs 2011; 29:984–995.

Souza-Dantas VC, Salluh JIF, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol 2011; 22:2094–2100.

Talour K, Abasq C, Sassolas B, Le Ru Y, et al. DRESS-like syndrome induced by shiitake mushroom. Eur J Dermatol 2011; 21:640–641.

Tesfa D, Ajeganova S, Hagglund H, Sander B, et al. Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections. Arthritis Rheum 2011; 63:2209–2214.

Teuffel O, Ethier MC, Alibhai SMH, Beyene J, et al. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol 2011; 22:2358–2365.

Teuffel O, Sung L. Advances in management of low-risk febrile neutropenia. Curr Opin Pediatr 2012; 24:40–45.

Urbonas V, Eidukaite A, Tamuliene I. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients. Cytokine 2012; 57:313–315.

Vanska M, Koivula I, Hamalainen S, Pulkki K, et al. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematol-Hematol J 2011; 96: 1385–1389.

Viglietti D, Peraldi MN. Cytopenias following kidney transplantation. Nephrol Ther 2011; 7:474–478.

Vukotic M, Oeljeklaus S, Wiese S, Vogtle FN, et al. Rcf1 Mediates Cytochrome Oxidase Assembly and Respirasome Formation, Revealing Heterogeneity of the Enzyme Complex. Cell Metab 2012; 15:336–347.

Wei CH, Hui RCY, Chang CJ, Ho HC, et al. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol 2011; 21:930–937.

Weissmann-Brenner A, Brenner B, Belyaeva I, Lahav M, et al. Rituximab associated neutropenia: Description of three cases and an insight into the underlying pathogenesis. Med Sci Monitor 2011; 17:CS133–CS137.

Wingard JR, Eldjerou L, Leather H. Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia. Curr Opin Hematol 2012; 19:21–26.

Wolach O, Shpilberg O, Lahav M. Neutropenia after rituximab treatment: new insights on a late complication. Curr Opin Hematol 2012; 19:32–38.

Woolner AF, Davidson A, Skinner R, King D. Evaluation of Infection Control Advice for Patients at Risk of Chemotherapy-Induced Neutropenia in 2 Pediatric Oncology Centers: Cape Town, South Africa, and Newcastle-Upon-Tyne, UK. Pediatr Hematol Oncol 2012; 29:73–84.

Ye Y, Carlsson G, Wondimu B, Fahlen A, et al. Mutations in the ELANE Gene are Associated with Development of Periodontitis in Patients with Severe Congenital Neutropenia. J Clin Immunol 2011; 31:936–945.

Soto E, Staab A, Doege C, Freiwald M et al. Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor. Cancer Chemother Pharmacol 2011; 68:1517-1527.

Neutrophil chemokine receptors

Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, et al. The phenotype of human STK4 deficiency. Blood 2012; 119:3450–3457.

Abohashem-Aly AA, Meng XZ, Li JL, Sadaria MR, et al. DITPA, A Thyroid Hormone Analog, Reduces Infarct Size and Attenuates the Inflammatory Response Following Myocardial Ischemia. J Surg Res 2011; 171:379–385.

Abu El-Asrar AM, Al-Obeidan SS, Kangave D, Geboes K, et al. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology 2011; 216:1004–1009.

Adeli EK, Abolghasemi H, Ebtekar M, Pourpak Z, et al. Effects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133(+) cells into megakaryocyte progenitor cells. Cytokine 2011; 55: 181–187.

Ajibade AA, Wang QF, Cui J, Zou J, et al. TAK1 Negatively Regulates NF-kappa B and p38 MAP Kinase Activation in Gr-1(+)CD11b(+) Neutrophils. Immunity 2012; 36:43–54.

Al-Jasmi F, Penefsky HS, Souid AK. The phosphorescence oxygen analyzer as a screening tool for disorders with impaired lymphocyte bioenergetics. Mol Genet Metab 2011; 104:529–536.

Al-Omari M, Korenbaum E, Ballmaier M, Lehmann U, et al. Acute-Phase Protein alpha 1-Antitrypsin Inhibits Neutrophil Calpain I and Induces Random Migration. Mol Med 2011; 17:865–874.

Almeida CB, Favero ME, Pereira-Cunha FG, Lorand-Metze I, et al. Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease. Exp Biol Med 2011; 236:1239–1246.

Ang SF, Sio SWS, Moochhala SM, MacAry PA, et al. Hydrogen Sulfide Upregulates Cyclooxygenase-2 and Prostaglandin E Metabolite in Sepsis-Evoked Acute Lung Injury via Transient Receptor Potential Vanilloid Type 1 Channel Activation. J Immunol 2011; 187:4778–4787.

Aulik NA, Hellenbrand KM, Czuprynski CJ. Mannheimia haemolytica and Its Leukotoxin Cause Macrophage Extracellular Trap Formation by Bovine Macrophages. Infect Immun 2012; 80:1923–1933.

Avalos BR, Lazaryan A, Copelan EA. Can G-CSF Cause Leukemia in Hematopoietic Stem Cell Donors? Biol Blood Marrow Transplant 2011; 17:1739–1746.

Awla D, Abdulla A, Regner S, Thorlacius H. TLR4 but not TLR2 regulates inflammation and tissue damage in acute pancreatitis induced by retrograde infusion of taurocholate. Inflamm Res 2011; 60:1093–1098.

Bacher U, Talano JA, Bishop MR. Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies. Biol Blood Marrow Transplant 2012; 18:S62–S73.

Balenga NAB, Aflaki E, Kargl J, Platzer W, et al. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res 2011; 21:1452–1469.

Banakar MK, Formosa M. Serum Thyroid Function Tests in Neonates of Mothers with Thyroid Disease. Indian J Pediatr 2011; 78:870–873.

Barin JG, Baldeviano GC, Talor MV, Wu L, et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 2012; 42:726–736.

Barros MP, Marin DP, Bolin AP, Macedo RDS, et al. Combined astaxanthin and fish oil supplementation improves glutathione-based redox balance in rat plasma and neutrophils. Chem-Biol Interact 2012; 197:58–67.

Barter EF, Stone MJ. Synergistic Interactions between Chemokine Receptor Elements in Recognition of Interleukin-8 by Soluble Receptor Mimics. Biochemistry 2012; 51:1322–1331.

Batkai S, Mukhopadhyay P, Horvath B, Rajesh M, et al. Delta(8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. Br J Pharmacol 2012; 165:2450–2461.

Baxley A, Akhtari M. Hematologic toxicities associated with intravenous immunoglobulin therapy. Int Immunopharmacol 2011; 11:1663–1667.

Bertini R, Barcelos LS, Beccari AR, Cavalieri B, et al. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor. Br J Pharmacol 2012; 165:436–454.

Bhan U, Newstead MJ, Zeng XY, Ballinger MN, et al. Stachybotrys chartarum-Induced Hypersensitivity Pneumonitis Is TLR9 Dependent. Am J Pathol 2011; 179: 2779–2787.

Bian Z, Li LM, Cui JL, Zhang HJ, et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011; 225:544–553.

Bidzan L, Bidzan M, Pachalska M. Aggressive and impulsive behavior in Alzheimer's disease and progression of dementia. Med Sci Monitor 2012; 18:CR182–CR189.

Bosmann M, Grailer JJ, Zhu KT, Matthay MA, et al. Anti-inflammatory effects of beta(2) adrenergic receptor agonists in experimental acute lung injury. Faseb J 2012; 26:2137–2144.

Bougarn S, Cunha P, Gilbert FB, Harmache A, et al. Staphylococcal-associated molecular patterns enhance expression of immune defense genes induced by IL-17 in mammary epithelial cells. Cytokine 2011; 56:749–759.

Breslow JM, Meissler JJ, Hartzell RR, Spence PB, et al. Innate Immune Responses to Systemic Acinetobacter baumannii Infection in Mice: Neutrophils, but Not Interleukin-17, Mediate Host Resistance. Infect Immun 2011; 79:3317–3327.

Brigotti M, Carnicelli D, Arfilli V, Rocchi L, et al. Change in Conformation with Reduction of alpha-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1. J Biol Chem 2011; 286:34514–34521.

Bruno DL, Stark Z, Amor DJ, Burgess T, et al. Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high-resolution SNP microarrays. Hum Mutat 2011; 32:1500–1506.

Buckley RH. The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol 2012; 129:597–606.

Butcher MJ, Gjurich BN, Phillips T, Galkina EV. The IL-17A/IL-17RA Axis Plays a Proatherogenic Role via the Regulation of Aortic Myeloid Cell Recruitment. CircRes 2012; 110:675–679.

Buzas K, Oppenheim JJ, Howard OMZ. Myeloid cells migrate in response to IL-24. Cytokine 2011; 55:429–434.

Byrne SN, Beaugie C, O'Sullivan C, Leighton S, et al. The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB Radiation. Am J Pathol 2011; 179: 211–222.

Caccamo N, La Mendola C, Orlando V, Meraviglia S, et al. Differentiation, phenotype, and function of interleukin-17-producing human V gamma 9 V delta 2 T cells. Blood 2011; 118:129–138.

Cai J, Zhang SN, Zheng M, Wu XQ, et al. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives. Bioorg Med Chem Lett 2012; 22:806–810.

Cai SS, Batra S, Wakamatsu N, Pacher P, et al. NLRC4 Inflammasome-Mediated Production of IL-1 beta Modulates Mucosal Immunity in the Lung against Gram-Negative Bacterial Infection. J Immunol 2012; 188:5623–5635.

Cantisani R, Sammicheli C, Tavarini S, D'Oro U, et al. Surface molecules on stimulated plasmacytoid dendritic cells are sufficient to cross-activate resting myeloid dendritic cells. Hum Immunol 2011; 72:1018–1021.

Carr KD, Sieve AN, Indramohan M, Break TJ, et al. Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur J Immunol 2011; 41:2666–2676.

Case SR, Martin RJ, Jiang D, Minor MN, et al. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp Lung Res 2011; 37:500–508.

Chan K, Davis J, Pai SY, Bonilla FA, et al. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab 2011; 104:383–389.

Chang MC, Wang TM, Yeung SY, Jeng PY, et al. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A(2) production. Atherosclerosis 2011; 219:559–565.

Chen DX, Shrivastava S, Ma L, Tham EL, et al. Inhibition of Thrombin Receptor Signaling on alpha-Smooth Muscle Actin(+) CD34(+) Progenitors Leads to Repair After Murine Immune Vascular Injury. Arterioscler Thromb Vasc Biol 2012; 32:42.

Chen M, Copland DA, Zhao JW, Liu J, et al. Persistent Inflammation Subverts Thrombospondin-1-Induced Regulation of Retinal Angiogenesis and Is Driven by CCR2 Ligation. Am J Pathol 2012; 180:235–245.

Chen ML, Tsai TC, Wang LK, Lin YY, et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils. Int Immunopharmacol 2012; 12:197–204.

Chen Y, Wu H, Winnall WR, Loveland KL, et al. Tumour necrosis factor-alpha stimulates human neutrophils to release preformed activin A. Immunol Cell Biol 2011; 89:889–896.

Chevalier X, Conrozier T, Richette P. Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy - art. no. 124. Arthritis Res Ther 2011; 13:124.

Chevigne A, Fievez V, Schmit JC, Deroo S. Engineering and screening the N-terminus of chemokines for drug discovery. Biochem Pharmacol 2011; 82:1438–1456.

Chinen J, Shearer WT. Advances in basic and clinical immunology in 2011. J Allergy Clin Immunol 2012; 129:342–348.

Choi SM, Liu H, Chaudhari P, Kim Y, et al. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood 2011; 118:1801–1805.

Clemente MJ, Wlodarski MW, Makishima H, Viny AD, et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 2011; 118:4384–4393.

Cocelli LP, Ugur MG, Karadasli H. Comparison of Effects of Low-Flow Sevoflurane and Desflurane Anesthesia on Neutrophil and T-Cell Populations. Curr Ther Res-Clin Exp 2012; 73:41–51.

Colmont CS, Raby AC, Dioszeghy V, Le Bouder E, et al. Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant 2011; 26:4079.

Connolly MK, Ayo D, Malhotra A, Hackman M, et al. Dendritic Cell Depletion Exacerbates Acetaminophen Hepatotoxicity. Hepatology 2011; 54:959–968.

Dabrazhynetskaya A, Ma JX, Guerreiro-Cacais AO, Arany Z, et al. Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules. J Cell Mol Med 2012; 16:129–141.

Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, et al. Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 2012; 119:3211–3218.

de Jonge HJM, Huls G, de Bont E. Gene expression profiling in acute myeloid leukaemia. Neth J Med 2011; 69:167–176.

Dixon DL, Griggs KM, Bersten AD, De Pasquale CG. Systemic inflammation and cell activation reflects morbidity in chronic heart failure. Cytokine 2011; 56:593–599.

Dominietto A, Tedone E, Soracco M, Bruno B, et al. In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT. Bone Marrow Transplant 2012; 47:101–106.

Dominis-Kramaric M, Bosnar M, Kelneric Z, Glojnaric I, et al. Comparison of Pulmonary Inflammatory and Antioxidant Responses to Intranasal Live and Heat-Killed Streptococcus pneumoniae in Mice. Inflammation 2011; 34:471–486.

Donnelly LE, Barnes PJ. Chemokine receptor cxcr2 antagonism to prevent airways inflammation. Drug Future 2011; 36:465–472.

Dumas A, Lagarde S, Laflamme C, Pouliot M. Oncostatin M decreases interleukin-1 ss secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo. J Cell Mol Med 2012; 16:1274–1285.

Dumas E, Martel C, Neagoe PE, Bonnefoy A, et al. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. Biochim Biophys Acta-Mol Cell Res 2012; 1823:358–367.

Dumitru CA, Gholaman H, Trellakis S, Bruderek K, et al. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 2011; 129:859–869.

El-Bietar J, Bollard C. T-Cell Therapies for Epstein-Barr Virus-Associated Lymphomas. Pediatr Hematol Oncol 2011; 28:627–639.

El-Hafidi M, Meschini MC, Rizza T, Santorelli FM, et al. Cardiolipin content in mitochondria from cultured skin fibroblasts harboring mutations in the mitochondrial ATP6 gene. J Bioenerg Biomembr 2011; 43:683–690.

Emami CN, Mittal R, Wang L, Ford HR, et al. Role of Neutrophils and Macrophages in the Pathogenesis of Necrotizing Enterocolitis Caused by Cronobacter sakazakii. J Surg Res 2012; 172:18–28.

Engel P, Perez-Carmona N, Alba MM, Robertson K, et al. Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production. Immunol Cell Biol 2011; 89:753–766.

Engelhardt KR, Grimbacher B. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 2012; 129:294–305.

Erdogan T, Cicek Y, Kocaman SA, Canga A, et al. Increased Serum Bilirubin Level is Related to Good Collateral Development in Patients with Chronic Total Coronary Occlusion. Intern Med 2012; 51:249–255.

Evangelou G, Farrar MD, White RD, Sorefan NB, et al. Topical aminolaevulinic acid-photodynamic therapy produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo. Br J Dermatol 2011; 165:513–519.

Feigelson SW, Grabovsky V, Manevich-Mendelson E, Pasvolsky R, et al. Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells. Blood 2011; 117:7042–7052.

Frangogiannis NG. Regulation of the Inflammatory Response in Cardiac Repair. CircRes 2012; 110:159–173.

Frankenberger M, Eder C, Hofer TPJ, Heimbeck I, et al. Chemokine Expression by Small Sputum Macrophages in COPD. Mol Med 2011; 17:762–770.

Frazer LC, O'Connell CM, Andrews CW, Zurenski MA, et al. Enhanced Neutrophil Longevity and Recruitment Contribute to the Severity of Oviduct Pathology during Chlamydia muridarum Infection. Infect Immun 2011; 79:4029–4041.

Fujie H, Niu K, Ohba M, Tomioka Y, et al. A Distinct Regulatory Role of Th17 Cytokines IL-17A and IL-17F in Chemokine Secretion from Lung Microvascular Endothelial Cells. Inflammation 2012; 35:1119–1131.

Fujino N, Kubo H, Suzuki T, He M, et al. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice. Exp Lung Res 2012; 38:28–36.

Fujita H, Kato T, Watanabe N, Takahashi T, et al. Calpain inhibitors stimulate phagocyte functions via activation of human formyl peptide receptors. Arch Biochem Biophys 2011; 513:51–60.

Gasparik V, Daubeuf F, Hachet-Haas M, Rohmer F, et al. Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo. ACS Med Chem Lett 2012; 3:10–14.

Gasparoto TH, de Oliveira CE, Vieira NA, Porto VC, et al. Activation pattern of neutrophils from blood of elderly individuals with -related denture stomatitis. Eur J Clin Microbiol Infect Dis 2012; 31:1271–1277.

Giner AM, Kuster SP, Zbinden R, Ruef C, et al. Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003–2009. Infection 2011; 39:519–526.

Gjertsen BT. Stratification of pediatric acute myeloid leukemia through cancer cell gene-expression profiling. Expert Rev Anticancer Ther 2011; 11:355–357.

Gokce M, Unal O, Hismi B, Gumruk F, et al. Secondary Hemophagocytosis in 3 Patients With Organic Acidemia Involving Propionate Metabolism. Pediatr Hematol Oncol 2012; 29:92–98.

Gougounon A, Abahssain H, Rigollet L, Elhamri M, et al. Minimally differentiated acute myeloid leukemia (FAB AML-M0): Prognostic factors and treatment effects on survival-A retrospective study of 42 adult cases. Leuk Res 2011; 35:1027–1031.

Gragnani L, Piluso A, Giannini C, Caini P, et al. Genetic Determinants in Hepatitis C Virus-Associated Mixed Cryoglobulinemia: Role of Polymorphic Variants of BAFF Promoter and Fc gamma Receptors. Arthritis Rheum 2011; 63:1446–1451.

Guo H, Gao JL, Wu XY. Toll-like receptor 2 siRNA suppresses corneal inflammation and attenuates Aspergillus fumigatus keratitis in rats. Immunol Cell Biol 2012; 90:352–357.

Gupta R, Webb-Myers R, Flanagan S, Buckland ME. Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications. J Clin Pathol 2011; 64:835–844.

Habib T, Funk A, Rieck M, Brahmandam A, et al. Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant. J Immunol 2012; 188:487–496.

Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol 2012; 47:1–8.

Hanafusa T, Azukizawa H, Matsumura S, Katayama I. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. J Dermatol Sci 2012; 65:213–219.

Hannelien V, Karel G, Jo VD, Sofie S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta-Rev Cancer 2012; 1825:117–129.

Harding M, Kubes P. Innate immunity in the vasculature: interactions with pathogenic bacteria. Curr Opin Microbiol 2012; 15:85–91.

Hasko G, Csoka B, Koscso B, Chandra R, et al. Ecto-5 '-Nucleotidase (CD73) Decreases Mortality and Organ Injury in Sepsis. J Immunol 2011; 187:4256–4267.

Hawryluk EB, Linskey KR, Duncan LM, Nazarian RM. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists. J Cutan Pathol 2012; 39:481–492.

Heinrich V, Lee CY. Blurred line between chemotactic chase and phagocytic consumption: an immunophysical single-cell perspective. J Cell Sci 2011; 124:3041–3051.

Helgason GV, Karvela M, Holyoake TL. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 2011; 118:2035–2043.

Heymann F, Hammerich L, Storch D, Bartneck M, et al. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology 2012; 55:898–909.

Hinton R, Petvises S, O'Neill H. Myelopoiesis related to perinatal spleen. Immunol Cell Biol 2011; 89:689–695.

Hope KJ, Sauvageau G. Roles for MSI2 and PROX1 in hematopoietic stem cell activity. Curr Opin Hematol 2011; 18:203–207.

Horvath B, Magid L, Mukhopadhyay P, Batkai S, et al. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury. Br J Pharmacol 2012; 165:2462–2478.

Horvath B, Mukhopadhyay P, Kechrid M, Patel V, et al. beta-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radic Biol Med 2012; 52:1325–1333.

Houimel M, Mazzucchelli L. hCXCR1 and hCXCR2 antagonists derived from combinatorial peptide libraries. Cytokine 2012; 57:322–331.

Hu N, Westra J, Rutgers A, Doornbos-Van der Meer B, et al. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration - art. no. R201. Arthritis Res Ther 2011; 13:R201.

Hu YP, Gale M, Shields J, Garron C, et al. Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leuk Lymphoma 2012; 53:130–138.

Huang YH, Wang PW, Tiao MM, Chou MH, et al. Glucocorticoid Modulates High-Mobility Group Box 1 Expression and Toll-Like Receptor Activation in Obstructive Jaundice. J Surg Res 2011; 170:E47–E55.

Huber-Lang M, Denk S, Fulda S, Erler E, et al. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Mol Immunol 2012; 50:60–65.

Hueber AJ, Alves-Filho JC, Asquith DL, Michels C, et al. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol 2011; 41:2229–2237.

Hung CY, Gonzalez A, Wuthrich M, Klein BS, et al. Vaccine Immunity to Coccidioidomycosis Occurs by Early Activation of Three Signal Pathways of T Helper Cell Response (Th1, Th2, and Th17). Infect Immun 2011; 79:4511–4522.

Ikeda-Matsuo Y, Tanji H, Narumiya S, Sasaki Y. Inhibition of prostaglandin E-2 EP3 receptors improves stroke injury via anti-inflammatory and anti-apoptotic mechanisms. J Neuroimmunol 2011; 238:34–43.

Ishii M, Asano K, Namkoong H, Tasaka S, et al. CRTH2 Is A Critical Regulator of Neutrophil Migration and Resistance to Polymicrobial Sepsis. J Immunol 2012; 188:5655–5664.

Iwasa T, Takahashi R, Nagata K, Kobayashi Y. Suppression of MIP-2 or IL-8 production by annexins A1 and A4 during coculturing of macrophages with late apoptotic human peripheral blood neutrophils. Biochim Biophys Acta-Mol Basis Dis 2012; 1822:204–211.

Jiang XD, Li GY, Li L, Dong Z, et al. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2011; 25:E171–E175.

John S, Manda S, Hamrock D. Cocaine-Induced Thrombotic Vasculopathy. Am J Med Sci 2011; 342:524–526.

Johnson JL, Hong H, Monfregola J, Catz SD. Increased Survival and Reduced Neutrophil Infiltration of the Liver in Rab27a-but Not Munc13-4-Deficient Mice in Lipopolysaccharide-Induced Systemic Inflammation. Infect Immun 2011; 79:3607–3618.

Johnson T, Nath A. Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 2011; 24:284–290.

Joubert P, Lajoie-Kadoch S, Wellemans V, Letuve S, et al. Expression and regulation of CCL15 by human airway smooth muscle cells. Clin Exp Allergy 2012; 42:85–94.

Juskewitch JE, Knudsen BE, Platt JL, Nath KA, et al. LPS-Induced Murine Systemic Inflammation Is Driven by Parenchymal Cell Activation and Exclusively Predicted by Early MCP-1 Plasma Levels. Am J Pathol 2012; 180:32–40.

Kamburova EG, Koenen H, Boon L, Hilbrands LB, et al. In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells. Am J Transplant 2012; 12:341–350.

Kaminuma O, Ohtomo T, Mori A, Nagakubo D, et al. Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4. Clin Exp Allergy 2012; 42:315–325.

Kaneda K, Saitoh F, Shibusawa H, Maegawa H, et al. Correlation of neutrophil and monocyte derived interleukin-1 receptor antagonist and interleukin-8 with colitis severity in the rabbit. Cytokine 2011; 56:508–514.

Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol 2011; 7:691–699.

Kasper B, Petersen F. Molecular pathways of platelet factor 4/CXCL4 signaling. Eur J Cell Biol 2011; 90:521–526.

Keestra AM, Godinez I, Xavier MN, Winter MG, et al. Early MyD88-Dependent Induction of Interleukin-17A Expression during Salmonella Colitis. Infect Immun 2011; 79:3131–3140.

Kim Y, Seo JH. Kim H. beta-Carotene and Lutein Inhibit Hydrogen Peroxide-Induced Activation of NF-kappa B and IL-8 Expression in Gastric Epithelial AGS Cells. J Nutr Sci Vitaminol 2011; 57:216–223.

Kolobovnikova YV, Urazova OI, Novitsky VV, Litvinova LS, et al. Eosinophil: a modern concept of the kinetics, structure, and function. Gematol Transfuziol 2012; 57:30–36.

Kornblau SM, Qiu YH, Zhang NX, Singh N, et al. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood 2011; 118:5604–5612.

Kosmidis CI, Chandrasekar PH. Management of gram-positive bacterial infections in patients with cancer. Leuk Lymphoma 2012; 53:8–18.

Kovach MA, Standiford TJ. The function of neutrophils in sepsis. Curr Opin Infect Dis 2012; 25:321–327.

Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmacol 2011; 11:1399–1406.

Kozako T, Yoshimitsu M, Akimoto M, White Y, et al. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Hum Immunol 2011; 72:1001–1006.

Kratochvill F, Machacek C, Vogl C, Ebner F, et al. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation - art. no. 560. Mol Syst Biol 2011; 7.

Kroger N, Miyamura K, Bishop MR. Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2011; 17:S94–S100.

Kuipers MT, Aslami H, Janczy JR, van der Sluijs KF, et al. Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome. Anesthesiology 2012; 116:1104–1115.

Kwissa M, Nakaya HI, Oluoch H, Pulendran B. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates. Blood 2012; 119:2044–2055.

Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, et al. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol 2011; 72:282–293.

Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol 2012; 166:1333–1341.

Lee CH, Kim YS, Kang NI, Lee YM, et al. IgG Immune Complex Induces the Recruitment of Inflammatory Cells into the Airway and TNF-Mediated Late Airway Hyperresponsiveness via NF-kappa B Activation in Mice. J Asthma 2011; 48:757–766.

Lee KY, Liu LJ, Jin Y, Fu SB, et al. Cdk5 mediates vimentin ser56 phosphorylation during GTP-induced secretion by neutrophils. J Cell Physiol 2012; 227:739–750.

Lee S, Takahashi I, Matsuzaka M, Yamai K, et al. The Relationship Between Serum Selenium Concentration and Neutrophil Function in Peripheral Blood. Biol Trace Elem Res 2011; 144:396–406.

Lefort CT, Rossaint J, Moser M, Petrich BG, et al. Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood 2012; 119:4275–4282.

Li ZJ, Burns AR, Miller SB, Smith CW. CCL20, gamma delta T cells, and IL-22 in corneal epithelial healing. Faseb J 2011; 25:2659–2668.

Liao AJ, Broeg K, Fox T, Tan SF, et al. Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia. Blood 2011; 118:2793–2800.

Lopez-Munoz A, Sepulcre MP, Roca FJ, Figueras A, et al. Evolutionary conserved pro-inflammatory and antigen presentation functions of zebrafish IFN gamma revealed by transcriptomic and functional analysis. Mol Immunol 2011; 48:1073–1083.

Lorenzi L, Lonardi S, Petrilli G, Tanda F, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol 2012; 43:209–215.

Losse J, Svobodova E, Heyken A, Hube B, et al. Role of pH-regulated antigen 1 of Candida albicans in the fungal recognition and antifungal response of human neutrophils. Mol Immunol 2011; 48:2135–2143.

Lu HY, Huang DP, Ransohoff RM, Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. Faseb J 2011; 25:3344–3355.

Lu J, Wu DM, Zheng YL, Hu B, et al. Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-alpha-mediated mitochondrial biogenesis signaling in mice. Free Radic Biol Med 2012; 52:646–659.

Magrone T, Jirillo E. Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions. Curr Pharm Design 2012; 18:1609–1619.

Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; Immunology. 11:519–531.

Marriott HM, Gascoyne KA, Gowda R, Geary I, et al. Interleukin-1 beta Regulates CXCL8 Release and Influences Disease Outcome in Response to Streptococcus pneumoniae, Defining Intercellular Cooperation between Pulmonary Epithelial Cells and Macrophages. Infect Immun 2012; 80:1140–1149.

Martin AK, Mack DG, Falta MT, Mroz MM, et al. Beryllium-specific CD4(+) T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol 2011; 128:1100.

McDermott DH, Lopez J, Deng F, Liu Q, et al. AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. J Cell Mol Med 2011; 15:2071–2081.

McElroy MK, Read WL, Harmon GS, Weidner N. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma. Ann Diagn Pathol 2011; 15:370–375.

McIntosh JH, Cochrane M, Cobbold S, Waldmann H, et al. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. Gene Ther 2012; 19:78–85.

Mehrotra S, Fakiola M, Oommen J, Jamieson SE, et al. Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India - art. no. 162. BMC Med Genet 2011; 12:15.

Mei JJ, Liu YH, Dai N, Hoffmann C, et al. Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J Clin Invest 2012; 122:974–986.

Melo GD, Machado GF. Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres. Cell Tissue Res 2011; 346:293–304.

Michelakakis H, Xiromerisiou G, Dardiotis E, Bozi M, et al. Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease. Mov Disord 2012; 27:400–405.

Mittal N, Sanyal SN. Effect of exogenous surfactant on phosphatidylinositol 3-kinase-Akt pathway and peroxisome proliferator activated receptor-gamma during endotoxin induced acute respiratory distress syndrome. Mol Cell Biochem 2012; 361:135–141.

Molzan M, Weyand M, Rose R, Ottmann C. Structural insights of the MLF1/14-3-3 interaction. Febs J 2012; 279:563–571.

Monaghan SF, Thakkar RK, Heffernan DS, Huang X, et al. Mechanisms of Indirect Acute Lung Injury A Novel Role for the Coinhibitory Receptor, Programmed Death-1. Ann Surg 2011; 255:158–164.

Moran EM, Connolly M, Gao W, McCormick J, et al. Interleukin-17A Induction of Angiogenesis, Cell Migration, and Cytoskeletal Rearrangement. Arthritis Rheum 2011; 63: 3263–3273.

Naegele M, Tillack K, Reinhardt S, Schippling S, et al. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol 2012; 242:60–71.

Nam YH, Min D, Kim HP, Song KJ, et al. Leukotriene B-4 receptor BLT-mediated phosphorylation of NF-kappa B and CREB is involved in IL-8 production in human mast cells induced by Trichomonas vaginalis-derived secretory products. Microbes Infect 2011; 13:1211–1220.

Narducci P, Bareggi R, Nicolin V. Receptor Activator for Nuclear Factor kappa B Ligand (RANKL) as an osteoimmune key regulator in bone physiology and pathology. Acta Histochem 2011; 113:73–81.

Nemeth T, Mocsai A. The role of neutrophils in autoimmune diseases. Immunol Lett 2012; 143:9–19.

Nepom GT, St Clair EW, Turka LA. Challenges in the pursuit of immune tolerance. Immunol Rev 2011; 241:49–62.

Ng HH, Narasaraju T, Phoon MC, Sim MK, et al. Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: Involvement of matrix metalloproteinases. Exp Mol Pathol 2012; 92:287–295.

Niu FN, Zhang X, Hu XM, Chen J, et al. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke. Brain Behav Immun 2012; 26:61–71.

Nowend KL, Starr-Moss AN, Murphy KE. The function of dog models in developing gene therapy strategies for human health. Mamm Genome 2011; 22:476–485.

Ormsby T, Schlecker E, Ferdin J, Tessarz AS, et al. Btk is a positive regulator in the TREM-1/DAP12 signaling pathway. Blood 2011; 118:936–945.

Ouederni M, Vincent QB, Frange P, Touzot F, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 2011; 118:5108–5118.

Owen JL, Criscitiello MF, Libreros S, Garcia-Areas R, et al. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice. Cell Immunol 2011; 270:172–182.

Pappa CA, Tsirakis G, Kanellou P, Kaparou M, et al. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Cytokine 2011; 56:616–620.

Paredes EM, Perez LG, Rodriguez AJG, Quiles DR, et al. Disseminated fusariosis in immunocompromised patients. Eur J Dermatol 2011; 21:753–755.

Paulsson JM, Moshfegh A, Dadfar E, Held C, et al. In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils. Clin Exp Immunol 2012; 168:105–112.

Pegolo E, Machin P, Riosa F, Bassini A, et al. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma Correlation With Histologic Sections Determination. Cancer Cytopathol 2012; 120:196–205.

Perreault S, Bernard G, Lortie A, Le Deist F, et al. Ataxia-Telangiectasia Presenting With a Novel Immunodeficiency. Pediatr Neurol 2012; 46:322–324.

Piedfer M, Dauzonne D, Tang RP, N'Guyen J, et al. Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells. Faseb J 2011; 25:2831–2842.

Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol 2011; 23:721–731.

Plumb J, Gaffey K, Kane B, Malia-Milanes B, et al. Reduced glucocorticoid receptor expression and function in airway neutrophils. Int Immunopharmacol 2012; 12:26–33.

Price ET, Welder GJ, Zineh I. Modulatory Effect of Fenofibrate on Endothelial Production of Neutrophil Chemokines IL-8 and ENA-78. Cardiovasc Drugs Ther 2012; 26:95–99.

Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circles. J Allergy Clin Immunol 2012; 129:607–618.

Rahim AA, Wong AMS, Hoefer K, Buckley SMK, et al. Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. Faseb J 2011; 25:3505–3518.

Ramadas RA, Roche MI, Moon JJ, Ludwig T, et al. CARMA1 Is Necessary for Optimal T Cell Responses in a Murine Model of Allergic Asthma. J Immunol 2011; 187:6197–6207.

Ramos-Romero S, Perez-Cano FJ, Perez-Berezo T, Castellote C, et al. Effect of a cocoa flavonoid-enriched diet on experimental autoimmune arthritis. Br J Nutr 2012; 107:523–532.

Rathinam C, Poueymirou WT, Rojas J, Murphy AJ, et al. Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood 2011; 118:3119–3128.

Rathore KI, Berard JL, Redensek A, Chierzi S, et al. Lipocalin 2 Plays an Immunomodulatory Role and Has Detrimental Effects after Spinal Cord Injury. J Neurosci 2011; 31:13412–13419.

Ravandi F. Primary refractory acute myeloid leukaemia - in search of better definitions and therapies. Br J Haematol 2011; 155:413–419.

Reber LL, Daubeuf F, Plantinga M, De Cauwer L, et al. A Dissociated Glucocorticoid Receptor Modulator Reduces Airway Hyperresponsiveness and Inflammation in a Mouse Model of Asthma. J Immunol 2012; 188:3478–3487.

Redmond SB, Chuammitri P, Andreasen CB, Palic D, et al. Genetic control of chicken heterophil function in advanced intercross lines: associations with novel and with known Salmonella resistance loci and a likely mechanism for cell death in extracellular trap production. Immunogenetics 2011; 63:449–458.

Reinoso R, Calonge M, Castellanos E, Martino M, et al. Differential Cell Proliferation, Apoptosis, and Immune Response in Healthy and Evaporative-Type Dry Eye Conjunctival Epithelia. Invest Ophthalmol Vis Sci 2011; 52:4819–4828.

Rider P, Carmi Y, Guttman O, Braiman A, et al. IL-1 alpha and IL-1 beta Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation. J Immunol 2011; 187:4835–4843.

Risueno RM, Campbell CJV, Dingwall S, Levadoux-Martin M, et al. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease. Blood 2011; 117:7112–7120.

Rocha FAC, Silva FS, Leite A, Leite A, et al. Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release. Br J Pharmacol 2011; 164:828–835.

Roderfeld M, Rath T, Pasupuleti S, Zimmermann M, et al. Bone marrow transplantation improves hepatic fibrosis in Abcb4(-/-) mice via Th1 response and matrix metalloproteinase activity. Gut 2012; 61:907–916.

Roncarolo MG, Gregori S, Lucarelli B, Ciceri F, et al. Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol Rev 2011; 241:145–163.

Rosenzweig SD, Holland SM. Recent Insights into the Pathobiology of Innate Immune Deficiencies. Curr Allergy Asthma Rep 2011; 11:369–377.

Roug AS, Nyvold CG, Juhl-Christensen C, Christensen M, et al. A patient with a 20-year lag phase between JAK2-V617F+myeloproliferation and NPM1-mutated AML arguing against a common origin of disease. Eur J Haematol 2011; 87:461–463.

Rougerie P, Delon J. Rho GTPases: Masters of T lymphocyte migration and activation. Immunol Lett 2012; 142:1–13.

Roy M, Richard JF, Dumas A, Vallieres L. CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis - art. no. 18. J Neuroinflamm 2012; 9:23.

Rudaks LI, Patel S, Barnett CP. Novel Clinical Features in Pontine Tegmental Cap Dysplasia. Pediatr Neurol 2012; 46:393–396.

Ruiz FS, Andersen ML, Martins RCS, Zager A, et al. Immune alterations after selective rapid eye movement or total sleep deprivation in healthy male volunteers. Innate Immun 2012; 18:44–54.

Russ AC, Sander S, Luck SC, Lang KM, et al. Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. Haematol-Hematol J 2011; 96:1783–1791.

Russell SM, Lechner MG, Gong L, Megiel C, et al. USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics. Oral Oncol 2011; Part B, Oral Oncology. 47:810–817.

Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, et al. Therapeutic Effects of Evasin-1, a Chemokine Binding Protein, in Bleomycin-Induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2011; 45:72–80.

Sanchez-Correa B, Gayoso I, Bergua JM, Casado JG, et al. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 2012; 90:109–115.

Sarkar A, Hellberg L, Bhattacharyya A, Behnen M, et al. Infection with Anaplasma phagocytophilum Activates the Phosphatidylinositol 3-Kinase/Akt and NF-kappa B Survival Pathways in Neutrophil Granulocytes. Infect Immun 2012; 80:1615–1623.

Schicho R, Bashashati M, Bawa M, McHugh D, et al. The Atypical Cannabinoid O-1602 Protects Against Experimental Colitis and Inhibits Neutrophil Recruitment. Inflamm Bowel Dis 2011; 17:1651–1664.

Schilling E, Wehrhahn J, Klein C, Raulien N, et al. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes. Innate Immun 2012; 18:518–530.

Schuette-Nuetgen K, Strecker JK, Minnerup J, Ringelstein EB, et al. MCP-1/CCR-2-double-deficiency severely impairs the migration of hematogenous inflammatory cells following transient cerebral ischemia in mice. Exp Neurol 2012; 233:849–858.

Schuh-Huerta SM, Johnson NA, Rosen MP, Sternfeld B, et al. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Hum Reprod 2012; 27:594–608.

Scian R, Barrionuevo P, Giambartolomei GH, De Simone EA, et al. Potential Role of Fibroblast-Like Synoviocytes in Joint Damage Induced by Brucella abortus Infection through Production and Induction of Matrix Metalloproteinases. Infect Immun 2011; 79:3619–3632.

Scotland RS, Stables MJ, Madalli S, Watson P, et al. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 2011; 118:5918–5927.

Shaw OM, Harper JL. Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis. Biochem Biophys Res Commun 2011; 416:266–269.

Shi C, Hohl TM, Leiner I, Equinda MJ, et al. Ly6G(+) Neutrophils Are Dispensable for Defense against Systemic Listeria monocytogenes Infection. J Immunol 2011; 187:5293–5298.

Shimizu T, Kaji A, Murayama C, Magata F, et al. Effects of interleukin-8 on estradiol and progesterone production by bovine granulosa cells from large follicles and progesterone production by luteinizing granulosa cells in culture. Cytokine 2012; 57:175–181.

Shore SA, Williams ES, Chen L, Benedito LAP, et al. Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1. Inhal Toxicol 2011; 23:878–888.

Sipkens JA, Krijnen PAJ, Hahn NE, Wassink M, et al. Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47(phox). Mol Cell Biochem 2011; 358:229–239.

Soehnlein O. Multiple Roles for Neutrophils in Atherosclerosis. CircRes 2012; 110:875–888.

Sokolic R, Maric I, Kesserwan C, Garabedian E, et al. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood 2011; 118:2688–2694.

Soustek MS, Falk DJ, Mah CS, Toth MJ, et al. Characterization of a Transgenic Short Hairpin RNA-Induced Murine Model of Tafazzin Deficiency. Hum Gene Ther 2011; 22:865–871.

Stadnyk AW, Carrigan SO, Otley AR. Neutrophil Transintestinal Epithelial Migration to CXCR2 Ligands Is Regulated by Adenosine. J Pediatr Gastroenterol Nutr 2012; 54:414–421.

Starr AE, Bellac CL, Dufour A, Goebeler V, et al. Biochemical Characterization and N-terminomics Analysis of Leukolysin, the Membrane-type 6 Matrix Metalloprotease (MMP25) CHEMOKINE AND VIMENTIN CLEAVAGES ENHANCE CELL MIGRATION AND MACROPHAGE PHAGOCYTIC ACTIVITIES. J Biol Chem 2012; 287:13382–13395.

Starr AE, Dufour A, Maier J, Overall CM. Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16. J Biol Chem 2012; 287:5848–5860.

Steingrimsdottir H, Einarsdottir HK, Haraldsdottir V, Ogmundsdottir HM. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members. Eur J Haematol 2011; 86:396–404.

Stern ME, Schaumburg CS, Siemasko KF, Gao JP, et al. Autoantibodies Contribute to the Immunopathogenesis of Experimental Dry Eye Disease. Invest Ophthalmol Vis Sci 2012; 53:2062–2075.

Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, et al. Transplanted CD34(+) Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma. Biol Blood Marrow Transplant 2011; 17:1146–1153.

Stoffers SL, Meyer SE, Grimes HL. MicroRNAs in the midst of myeloid signal transduction. J Cell Physiol 2012; 227:525–533.

Subramanian H, Gupta K, Guo Q, Price R, et al. Mas-related Gene X2 (MrgX2) Is a Novel G Protein-coupled Receptor for the Antimicrobial Peptide LL-37 in Human Mast Cells RESISTANCE TO RECEPTOR PHOSPHORYLATION, DESENSITIZATION, AND INTERNALIZATION. J Biol Chem 2011; 286:44739–44749.

Sumoza-Toledo A, Lange I, Cortado H, Bhagat H, et al. Dendritic cell maturation and chemotaxis is regulated by TRPM2-mediated lysosomal Ca2+ release. Faseb J 2011; 25:3529–3542.

Syu GD, Chen HI, Jen CJ. Differential Effects of Acute and Chronic Exercise on Human Neutrophil Functions. Med Sci Sports Exerc 2012; 44:1021–1027.

Szmydynger-Chodobska J, Strazielle N, Gandy JR, Keefe TH, et al. Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier. J Cereb Blood Flow Metab 2012; 32:93–104.

Takahashi N, Kozai D, Kobayashi R, Ebert M, et al. Roles of TRPM2 in oxidative stress. Cell Calcium 2011; 50:279–287.

Takayama S, Tamaoka M, Takayama K, Okayasu K, et al. Synthetic double-stranded RNA enhances airway inflammation and remodelling in a rat model of asthma. Immunology 2011; 134:140–150.

Takeuchi K, Umeki Y, Matsumoto N, Yamamoto K, et al. Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan. Inflamm Res 2012; 61:197–205.

Tan XW, Beuerman RW, Poh CK, Mehta JS. Tafazzin regulates human conjunctiva epithelial cell proliferation via inhibiting TGF beta signaling pathway. Mol Vis 2012; 18:1402–1410.

Tang EHC, Libby P, Vanhoutte PM, Xu AM. Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases. J Cardiovasc Pharmacol 2012; 59:116–123.

Tang HF, Yan CG, Cao J, Sarma JV, et al. An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation. Faseb J 2011; 25:4292–4300.

Tanga A, Saidi A, Jourdan ML, Dallet-Choisy S, et al. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases. Biochem Pharmacol 2012; 83:1663–1673.

Tazzyman S, Barry ST, Ashton S, Wood P, et al. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. Int J Cancer 2011; 129:847–858.

Thaher F, Plankenhorn S, Klein R. Differential effects of the tumor necrosis factor alpha-blocker infliximab and etanercept on immunocompetent cells in vitro. Int Immunopharmacol 2011; 11:1724–1731.

Thompson AL, Johnson BT, Sempowski GD, Gunn MD, et al. Maximal Adjuvant Activity of Nasally Delivered IL-1 alpha Requires Adjuvant-Responsive CD11c(+) Cells and Does Not Correlate with Adjuvant-Induced In Vivo Cytokine Production. J Immunol 2012; 188:2834–2846.

Tittel AP, Heuser C, Ohliger C, Llanto C, et al. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat Methods 2012; 9:385–399.

Treppendahl MB, Qiu XN, Sogaard A, Yang XJ, et al. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome inAML. Blood 2012; 119:206–216.

Troese MJ, Kahlon A, Ragland SA, Ottens AK, et al. Proteomic Analysis of Anaplasma phagocytophilum during Infection of Human Myeloid Cells Identifies a Protein That Is Pronouncedly Upregulated on the Infectious Dense-Cored Cell. Infect Immun 2011; 79:4696–4707.

Ueno K, Nomura Y, Masamoto I, Masuda K, et al. Potential Role of Autoantibody in Severe Neutropenia of a Patient with Kawasaki Syndrome. Scand J Immunol 2012; 75:120–126.

Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, et al. Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy. J Clin Oncol 2012; 30:1476–1483.

van de Ven R, Lindenberg JJ, Reurs AW, Scheper RJ, et al. Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP). Immunol Cell Biol 2012; 90:206–215.

Van Etten RA, Koschmieder S, Delhommeau F, Perrotti D, et al. The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues. Haematol-Hematol J 2011; 96:590–601.

Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, Haydu JE, et al. ETV6 mutations in early immature human T cell leukemias. J Exp Med 2011; Dec 2011; 208:2571–2579.

Vasu S, Caligiuri MA. Targeted immunotherapy for acute myeloid leukemia. Best Pract Res Clin Haematol 2011; 24:533–540.

Veenstra M, Ransohoff RM. Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller? J Neuroimmunol 2012; 246:1–9.

Verbeke H, Struyf S, Laureys G, Van Damme J. The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev 2011; 22:345–358.

Vermeesch JR, Brady PD, Sanlaville D, Kok K, et al. Genome-Wide Arrays: Quality Criteria and Platforms to be Used in Routine Diagnostics. Hum Mutat 2012; 33:906–915.

Vieira SM, Cunha TM, Franca RFO, Pinto LG, et al. Joint NOD2/RIPK2 Signaling Regulates IL-17 Axis and Contributes to the Development of Experimental Arthritis. J Immunol 2012; 188:5116–5122.

Vojdani A, Lambert J. The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II. Evid-based Complement Altern Med 2011.

von Bruhl ML, Stark K, Steinhart A, Chandraratne S, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2011; Dec 2012; 209:819–835.

Wang F, Song WS, Brancati G, Segatori L. Inhibition of Endoplasmic Reticulum-associated Degradation Rescues Native Folding in Loss of Function Protein Misfolding Diseases. J Biol Chem 2011; 286:43454–43464.

Wang LH, Chang GQ, Zhang HJ, Wang J, et al. Neutrophil gelatinase-associated lipocalin regulates intracellular accumulation of Rh123 in cancer cells. Genes Cells 2012; 17:205–217.

Wang QX, Li XK. Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol 2011; 11:373–376.

Wang Y, Robertson JD, Walcheck B. Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation. J Biol Chem 2011; 286:38980–38988.

Warlick ED, Defor T, Blazar BR, Burns L, et al. Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2012; 18:480–486.

Warlick ED, Miller JS. Myelodysplastic syndromes: the role of the immune system in pathogenesis. Leuk Lymphoma 2011; 52:2045–2049.

Watters RJ, Liu X, Loughran TP. T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma 2011; 52:2217–2225.

Wiede F, Shields BJ, Chew SH, Kyparissoudis K, et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 2011; 121:4758–4774.

Wisniewski JA, Borish L. Novel cytokines and cytokine-producing T cells in allergic disorders. Allergy Asthma Proc 2011; 32:83–94.

Wu LY, Li X, Su JY, He Q, et al. Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS. J Cancer Res Clin Oncol 2011; 137:1563–1569.

Wu XD, Zhang B, Fan R, Zhao L, et al. U50,488H inhibits neutrophil accumulation and TNF-alpha induction induced by ischemia-reperfusion in rat heart. Cytokine 2011; 56:503–507.

Wu YN, Wang S, Farooq SM, Castelvetere MP, et al. A Chemokine Receptor CXCR2 Macromolecular Complex Regulates Neutrophil Functions in Inflammatory Diseases. J Biol Chem 2012; 287:5744–5755.

Wurster VM, Carlucci JG, Edwards KM. Periodic Fever Syndromes. Pediatr Annu 2011; 40:48–54.

Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, et al. Innate Immunity against Granulibacter bethesdensis, an Emerging Gram-Negative Bacterial Pathogen. Infect Immun 2012; 80:975–981.

Zarpelon AC, Pinto LG, Cunha TM, Vieira SM, et al. Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNF alpha and CXCL1/CXCR2 in mice. Can J Physiol Pharmacol 2012; 90:187–199.

Zhang X, Huang H, Yang TT, Ye Y, et al. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Injury-Int J Care Inj 2010; 41:746–752.

Zhang Y, Patel B, Dey A, Ghorani E, et al. Attenuated, Oncolytic, but Not Wild-Type Measles Virus Infection Has Pleiotropic Effects on Human Neutrophil Function. J Immunol 2012; 188:1002–1010.

Zhou W, Gong YF, Lu X, Huang CT, et al. Molecular cloning and characterization of a flavonoid 3′-hydroxylase gene from purple-fleshed sweet potato (Ipomoea batatas). Mol Biol Rep 2012; 39:295–302.

Update on DRESS Syndrome

Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: an update on pathophysiology and treatment. Br Med Bull 2011; 100:59–72.

Bauer KA, Brimhall AK, Chang TT. Drug reaction with eosinophilia and systemic symptoms (dress) associated with azithromycin in acute epstein-barr virus infection. Pediatr Dermatol 2011; 28:741–743.

Blumenthal KG, Patil SU, Long ADA. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (dress) syndrome. Allergy Asthma Proc 2012; 33:165–171.

Bourgeois GP, Cafardi JA, Groysman V, Hughey LC. A review of DRESS-associated myocarditis. J Am Acad Dermatol 2012; 66:E229–E236.

Bourgeois GP, Cafardi JA, Groysman V, Pamboukian SV, et al. Fulminant myocarditis as a late sequela of DRESS: Two cases. J Am Acad Dermatol 2011; 65:889–890.

Brigotti M, Carnicelli D, Arfilli V, Rocchi L, et al. Change in Conformation with Reduction of alpha-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1. J Biol Chem 2011; 286:34514–34521.

Confavreux CB, Canoui-Poitrine F, Schott AM, Ambrosi V, et al. Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database. Eur J Endocrinol 2012; 166:735–741.

Daveluy A, Milpied B, Barbaud A, Lebrun-Vignes B, et al. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? Eur J Clin Pharmacol 2012; 68:101–105.

Descamps V. DRESS or 'picture of DRESS'. Bone Marrow Transplant 2012; 47:317.

Dioun AF. Management of Multiple Drug Allergies in Children. Curr Allergy Asthma Rep 2012; 12:79–84.

Dobros W, Burda K, Guzik K, Koziel J, et al. Apoptotic cell clearance in chronic inflammation of lateral neck cysts. Eur Arch Oto-Rhino-Laryn 2012; 269:965–970.

Doring Y, Manthey HD, Drechsler M, Lievens D, et al. Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis. Circulation 2012; 125:1673.

Ezzouine H, Charra B, Benslama A, Motaouakkil S. Respiratory distress revealed a DRESS syndrome. Ann Fr Anest Reanim 2011; 30:855–856.

Funck-Brentano E, Duong T, Family D, Bouaziz JD, et al. Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation. Ann Dermatol Venereol 2011; 138:580–585.

Gatt S, Dagan A. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chem Phys Lipids 2012; 165:462–474.

Horn M, Bertling A, Brodde MF, Muller A, et al. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. J Thromb Haemost 2012; 10:647–661.

Isik S, Tuncyurek P, Zengin NI, Demirbag AE, et al. Antithrombin Prevents Apoptosis by Regulating Inflammation in the Liver in a Model of Cold Ischemia/Warm Reperfusion Injury. Hepato-Gastroenterol 2012; 59:453–457.

Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012; 32:8–20.

James TY, Berbee ML. No jacket required - new fungal lineage defies dress code. Bioessays 2012; 34:94–102.

Kano Y, Horie C, Inaoka M, Tadashi I, et al. Herpes Zoster in Patients with Drug-induced Hypersensitivity Syndrome/DRESS. Acta Derm-Venereol 2012; 92:206–207.

Kumar A, Goldfarb JW, Bittner EA. A case of drug rash with eosinophilia and systemic symptoms (DRESS) syndrome complicating airway management. Can J Anesth 2012; 59:295–298.

Lehloenya RJ, Dheda K. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future. Expert Rev Anti-Infect Ther 2012; 10:475–486.

Lopez-Anglada L, Vazquez L, Perez-Simon JA, Davila I, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant. Bone Marrow Transplant 2011; 46:1487–1488.

McHale CM, Zhang LP, Smith MT. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis 2012; 33:240–252.

Midon M, Gimadutdinow O, Meiss G, Friedhoff P, et al. Chemical Rescue of Active Site Mutants of S. pneumoniae Surface Endonuclease EndA and Other Nucleases of the HNH Family by Imidazole. ChemBioChem 2012 Mar 2012; 13:713–721.

Mori Y, Yamaguchi M, Terao Y, Hamada S, et al. alpha-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps. J Biol Chem 2012; 287:10472–10481.

Mulligan CM, Sparagna GC, Le CH, De Mooy AB, et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc Res 2012; 94:460–468.

Murata T, Endo Y, Katoh M, Miyachi Y. Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7. J Dermatol 2011; 38:918–920.

Natkunarajah J, Goolamali S, Craythorne E, Benton E, et al. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. Eur J Dermatol 2011; 21:385–391.

Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 2011; 9:76–91.

Ott H. Cutaneous adverse drug reactions in childhood and adolescence. Hautarzt 2012; 63:97–103.

Ott H. Cutaneous adverse drug reactions in childhood and adolescence. Monschr Kinderheilkd 2011; 159:1094.

Pierce JD, Knight AR, Slusser JG, Gajewski BJ, et al. Effects of Fluid Resuscitation and Dopamine on Diaphragm Performance, Hydrogen Peroxide, and Apoptosis Following Hemorrhagic Shock in a Rat Model. Milit Med 2011; 176:336–342.

Pileri A, Brunasso AMG, Tilz H, Wolf P, et al. Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol 2011; 21:624–625.

Plotz SG, Huttig B, Aigner B, Merkel C, et al. Clinical Overview of Cutaneous Features in Hypereosinophilic Syndrome. Curr Allergy Asthma Rep 2012; 12:85–98.

Scherer M, Schmitz G. Metabolism, function and mass spectrometric analysis of bis(monoacylglycero)phosphate and cardiolipin. Chem Phys Lipids 2011; 164:556–562.

Schnetzke U, Bossert T, Scholl S, Freesmeyer M, et al. Drug-induced lymphadenopathy with eosinophilia and renal failure mimicking lymphoma disease: dramatic onset of DRESS syndrome associated with antibiotic treatment. Ann Hematol 2011; 90:1353–1355.

Sharma N, Rosenstiel SF, Fields HW, Beck FM. Smile characterization by u.s. white, u.s. asian indian, and indian populations. J Prosthet Dent 2012; 107:327–335.

Shimizu K, Libby P, Rocha VZ, Folco EJ, et al. Loss of Myeloid Related Protein-8/14 Exacerbates Cardiac Allograft Rejection. Circulation 2011; 124:2920.

Talour K, Abasq C, Sassolas B, Le Ru Y, et al. DRESS-like syndrome induced by shiitake mushroom. Eur J Dermatol 2011; 21:640–641.

Trankner A, Hass N, Simonis G, Braun-Dullaeus R, et al. 19-year-old asthma patient with pronounced eosinophilia and acute coronary syndrome. Internist 2011; 52:1479–1483.

Triggiani M, Loffredo S, Granata F, Staiano RI, et al. Modulation of Mast Cell and Basophil Functions by Benzene Metabolites. Curr Pharm Design 2011; 17:3830–3835.

Valenti C, Giuliani S, Cialdai C, Tramontana M, et al. Fasitibant chloride, a kinin B2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats. Br J Pharmacol 2012; 166:1403–1410.

Wang Z, Chen YW, Zhang JN, Hu XF, et al. Pentoxifylline attenuates cigarette smoke-induced overexpression of CXCR3 and IP-10 in mice. Chin Med J 2012; 125:1980–1985.

Wei CH, Hui RCY, Chang CJ, Ho HC, et al. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol 2011; 21:930–937.

Wojciechowska C, Gala A, Kuczaj A, Jachec W, et al. Heart Failure Mimicking Prior Myocardial Infarction in a Patient With Idiopathic Hypereosinophilic Syndrome. Int Heart J 2011; 52:194–196.

Yang S, Tang XF, Ma NN, Wang LY, et al. Heterology expression of the sweet pepper CBF3 gene confers elevated tolerance to chilling stress in transgenic tobacco. J Plant Physiol 2011; 168:1804–1812.

Yazicioglu M, Elmas R, Turgut B, Genchallac T. The association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells. Pediatr Allergy Immunol 2012; 23:289–296.

Update on diagnosis and management of hypereosinophilia

Audrain M, Martin J, Fromont P, Prie N, et al. Autoimmune neutropenia in children: analysis of 116 cases. Pediatr Allergy Immunol 2011; 22:494–496.

Ayhan AC, Timur C, Ayhan Y, Cakir B, et al. Does Hypereosinophilic Syndrome Precede Common B Acute Lymphoblastic Leukaemia in Childhood? A Case Report. Acta Haematol 2012; 127:90–92.

Ellis RJ, Badiee J, Vaida F, Letendre S, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. Aids 2011; 25:1747–1751.

Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011; 86:678–688.

Lammel V, Stoeckle C, Padberg B, Zweifel R, et al. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer 2012; 76:493–495.

Perl L, Pasvolsky O, Lifshitz L, Mekori YA, et al. Increased eosinophilic responses in splenectomized patients. Ann Allergy Asthma Immunol 2012; 108:34–38.

Verstraeten AS, De Weerdt A, van Den EG, Van Marck E, et al. Excessive eosinophilia as paraneoplastic syndrome in a patient with non-small-cell lung carcinoma: a case report and review of the literature. Acta Clin Belg 2011; 66:293–297.

Wongkitisophon P, Chanprapaph K, Rattanakaemakorn P, Vachiramon V. Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms. Acta Derm-Venereol 2012; 92:200–205.

Hematological manifestation of Cohen Syndrome

Baker CJ, Byington CL, Polin RA, Brady MT, et al. Policy Statement-Recommendations for the Prevention of Perinatal Group B Streptococcal (GBS) Disease. Pediatrics 2011; 128:611–616.

Baldawa SS, Sharma A. Comments on the article entitled ‘‘The Geriatric Scoring System (GSS) in meningioma patients-validation’' by Cohen-Inbar O, Sviri GE, Soustiel JF, Zaaroor M. Acta Neurochir 2011; 153:1501-1508. Acta Neurochir 2011; 153:2287-2288.

De Pasquale MD, Mastronuzzi A, De Vito R, Cometa A, et al. Unmanipulated Donor Lymphocytes for EBV-Related PTLD After T-Cell Depleted HLA-Haploidentical Transplantation. Pediatrics 2012; 129:E189–E194.

Dierickx D, Cortoos A, Van derschueren S. The haemophagocytic syndrome. Acta Clin Belg 2011; 66:448–452.

Farag SS. The potential role of Aurora kinase inhibitors in haematological malignancies. Br J Haematol 2011; 155:561–579.

Isaac G, Sinclair S. RESPONSE DePuy Orthopaedics replies to Deborah Cohen - art. no. e3146. Br Med J3146; 344:8..

Kim SY, Solomon DH, Liu J, Chang CL, et al. Accuracy of identifying neutropenia diagnoses in outpatient claims data. Pharmacoepidemiol Drug Saf 2011; 20:709–713.

Matsumoto S, Mizutani M, Sakata K, Shimizu BI. Molecular cloning and functional analysis of the ortho-hydroxylases of p-coumaroyl coenzyme A/feruloyl coenzyme A involved in formation of umbelliferone and scopoletin in sweet potato, Ipomoea batatas (L.) Lam. Phytochemistry 2012; 74:49–57.

Molenaar N, Beishuizen A, Groeneveld JAB. Dismissal of the utility of free cortisol measurement is premature: response to Cohen et al. Intensive Care Med 2012; 38:719–720.

Rattan SIS. Biogerontology: from here to where? The Lord Cohen Medal Lecture-2011. Biogerontology 2012; 13:83–91.

Sedwick C, Cohen-Fix O. Orna Cohen-Fix: Playing with nuclear morphology. J Cell Biol 2012; 196:550–551.

Seifert W, Kuhnisch J, Maritzen T, Horn D, et al. Cohen Syndrome-associated Protein, COH1, Is a Novel, Giant Golgi Matrix Protein Required for Golgi Integrity. J Biol Chem 2011; 286:37665–37675.

Taylor CA. Development of a modified Cohen method of standard setting. Med Teach 2011; 33:E678–E682.

Treesukosol Y, Smith KR, Spector AC. The functional role of the T1R family of receptors in sweet taste and feeding. Physiol Behav 2011; 105:14–26.

Wu P, Morey TE, Harris NS, Gravenstein N, et al. Intravenous Fluids Cause Systemic Bias in a Conductivity-Based Point-of-Care Hematocrit Meter. Anesth Analg 2012; 114:314–321.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins